AI assistant
Altek — Interim / Quarterly Report 2017
Nov 14, 2017
52290_rns_2017-11-14_d8001666-c50a-4271-b9d4-917cffeeae19.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS AND
REVIEW REPORT OF INDEPENDENT
ACCOUNTANTS
SEPTEMBER 30, 2017 AND 2016
REVIEW REPORT OF INDEPENDENT ACCOUNTANTS TRANSLATED FROM CHINESE
PWCR 17000104 (In Thousands of New Taiwan Dollars)
To Altek Corporation
We have reviewed the accompanying consolidated balance sheets of Altek Corporation and subsidiaries as of September 30, 2017 and 2016, and the related consolidated statements of comprehensive income for the three-month and nine-month periods then ended, as well as the consolidated statements of changes in equity and of cash flows for the nine-month periods then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express a conclusion on these financial statements based on our reviews.
Except as discussed in the following paragraph, we conducted our reviews in accordance with the Statement of Auditing Standards No. 36 “ Engagements to Review Financial Statements” in the Republic of China. A review consists primarily of inquiries of company personnel and analytical procedures applied to financial data. It is substantially less in scope than an audit conducted in accordance with generally accepted auditing standards in the Republic of China, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
As explained in Note 4(3), we did not review the financial statements of insignificant consolidated subsidiaries, which statements reflect total assets of $4,138,671 and $3,535,360, constituting 28% and 24% of the consolidated total assets, and total liabilities of $355,857 and $654,723, constituting 6% and 11% of the consolidated total liabilities as of September 30, 2017 and 2016, respectively, and total comprehensive income of $40,372, $70,551, $108,247, and $84,196, constituting 15%, 24%, 11% and 17% of the absolute values of the consolidated total comprehensive income for the three-month and nine-month periods ended September 30, 2017 and 2016, respectively. As described in Note 6(6) to the consolidated financial statements, the financial statements of investments accounted for under the equity method were not reviewed by independent accountants. Equity method investments in these investee companies had book values amounting to $0 and $128,245 as of September 30, 2017 and 2016,
~1~
respectively, and the related investment income both amounted to $0 for the three-month and nine-month periods then ended. These amounts were based solely on their unreviewed financial statements.
Based on our reviews, except for the effect of such adjustments, if any, as might have been determined to be necessary had the financial statements of subsidiaries and investee companies been reviewed by independent accountants as described in the preceding paragraph, we are not aware of any material modifications that should be made to the consolidated financial statements referred to in the first paragraph in order for them to be in conformity with the “Rules Governing the Preparation of Financial Statements by Securities Issuers” and International Accounting Standard 34 “Interim Financial Reporting”, as endorsed by the Financial Supervisory Commission.
Li, Tien-Yi[Lin, Yu-Kuan ]
For and on behalf of PricewaterhouseCoopers, Taiwan
November 13, 2017
------------------------------------------------------------------------------------------------------------------------------------------------The accompanying consolidated financial statements are not intended to present the financial position and results of operations and cash flows in accordance with accounting principles generally accepted in countries and jurisdictions other than the Republic of China. The standards, procedures and practices in the Republic of China governing the audit of such financial statements may differ from those generally accepted in countries and jurisdictions other than the Republic of China. Accordingly, the accompanying consolidated financial statements and report of independent accountants are not intended for use by those who are not informed about the accounting principles or auditing standards generally accepted in the Republic of China, and their applications in practice.
As the financial statements are the responsibility of the management, PricewaterhouseCoopers cannot accept any liability for the use of, or reliance on, the English translation or for any errors or misunderstandings that may derive from the translation.
~2~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS
(Expressed in thousands of New Taiwan dollars)
(The consolidated balance sheets as of September 30, 2017 and 2016 are reviewed, not audited)
| Assets | Notes | September 30, 2017 AMOUNT % $5,757,84538862,1376--2,143,3451419,045-6,418-1,141,3668165,726123,579-10,119,46167158,0191--4,279,72429205,541179,864196,581165,562-4,885,29133$15,004,752100 |
December 31, 2016 AMOUNT % $4,849,98932693,7095349-2,783,1451819,943-3,628-1,470,97110210,016119,772-10,051,52266147,8341126,75714,657,84831--92,917169,782-80,472-5,175,61034$15,227,132100 |
September 30, 2016 |
|---|---|---|---|---|
AMOUNT$5,757,845862,137-2,143,34519,0456,4181,141,366165,72623,57910,119,461158,019-4,279,724205,54179,86496,58165,5624,885,291$15,004,752 |
AMOUNT$4,849,989693,7093492,783,14519,9433,6281,470,971210,01619,77210,051,522147,834126,7574,657,848-92,91769,78280,4725,175,610$15,227,132 |
AMOUNT % $4,722,22232852,9386882-2,321,7771616,678-2,767-1,329,5839237,213124,296-9,508,35664156,2181128,24514,761,28332--94,449163,919-82,27415,286,38836$14,794,744100 |
||
| Current assets 1100 Cash and cash equivalents 1110 Current financial assets at fair value through profit or loss 1150 Notes receivable, net 1170 Accounts receivable, net 1200 Other receivables 1220 Current income tax assets 130X Inventories, net 1410 Prepayments 1470 Other current assets 11XX Current Assets Non-current assets 1543 Non-current financial assets at cost 1550 Investments accounted for using equity method 1600 Property, plant and equipment, net 1760 Investment property, net 1780 Intangible assets, net 1840 Deferred income tax assets 1900 Other non-current assets 15XX Non-current assets 1XXX Total assets |
6(1) 6(2) 6(3) 6(4) 6(5) 6(6) 6(7) 6(8) 6(9) 6(10) |
(Continued)
~3~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS
(Expressed in thousands of New Taiwan dollars)
(The consolidated balance sheets as of September 30, 2017 and 2016 are reviewed, not audited)
| September 30, 2017 | September 30, 2017 | December 31, 2016 | December 31, 2016 | September 30, 2016 | September 30, 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities and Equity | Notes | AMOUNT | % | AMOUNT | % | AMOUNT | % | ||||||||
| Current liabilities | |||||||||||||||
| 2100 | Short-term borrowings | 6(11) | $ |
2,366,000 |
16 |
$ |
2,415,000 |
16 |
$ |
2,225,000 |
15 |
||||
| 2150 | Notes payable | - |
- |
- |
- |
2,010 |
- |
||||||||
| 2170 | Accounts payable | 1,874,940 |
13 |
2,417,239 |
16 |
2,118,755 |
15 |
||||||||
| 2200 | Other payables | 427,830 |
3 |
445,206 |
3 |
711,799 |
5 |
||||||||
| 2230 | Current income tax liabilities | 58,194 |
- |
79,253 |
1 |
41,871 |
- |
||||||||
| 2250 | Provisions for liabilities - | 6(14) | |||||||||||||
| current | 49,642 |
- |
52,247 |
- |
28,285 |
- |
|||||||||
| 2300 | Other current liabilities | 194,985 |
1 |
204,924 |
1 |
195,039 |
1 |
||||||||
| 21XX | Current Liabilities | 4,971,591 |
33 |
5,613,869 |
37 |
5,322,759 |
36 |
||||||||
| Non-current liabilities | |||||||||||||||
| 2550 | Provisions for liabilities - | 6(14) | |||||||||||||
| noncurrent | 88,436 |
1 |
121,819 |
1 |
116,178 |
1 |
|||||||||
| 2570 | Deferred income tax liabilities | 416,571 |
3 |
442,112 |
3 |
423,433 |
3 |
||||||||
| 2600 | Other non-current liabilities | 30,370 |
- |
16,339 |
- |
29,672 |
- |
||||||||
| 25XX | Non-current liabilities | 535,377 |
4 |
580,270 |
4 |
569,283 |
4 |
||||||||
| 2XXX | Total Liabilities | 5,506,968 |
37 |
6,194,139 |
41 |
5,892,042 |
40 |
||||||||
| Equity attributable to owners of | |||||||||||||||
| parent | |||||||||||||||
| Share capital | 6(15) | ||||||||||||||
| 3110 | Common stock | 2,738,688 |
19 |
2,739,788 |
18 |
2,739,788 |
18 |
||||||||
| Capital surplus | 6(16) | ||||||||||||||
| 3200 | Capital surplus | 2,231,150 |
15 |
1,862,914 |
12 |
1,862,914 |
13 |
||||||||
| Retained earnings | 6(17) | ||||||||||||||
| 3310 | Legal reserve | 1,379,754 |
9 |
1,374,374 |
9 |
1,374,374 |
9 |
||||||||
| 3320 | Special reserve | 142,456 |
1 |
142,456 |
1 |
142,456 |
1 |
||||||||
| 3350 | Unappropriated retained | ||||||||||||||
| earnings | 2,729,293 |
18 |
2,946,092 |
19 |
2,851,391 |
19 |
|||||||||
| Other equity interest | 6(18) | ||||||||||||||
| 3400 | Other equity interest | ( |
256,434) ( |
2) ( |
25,521) |
- ( |
63,567) |
- |
|||||||
| 3500 | Treasury stocks | 6(15) | ( |
129,393) ( |
1) ( |
129,393)( |
1) ( |
129,393) ( |
1) |
||||||
| 31XX | Equity attributable to | ||||||||||||||
| owners of the parent | 8,835,514 |
59 |
8,910,710 |
58 |
8,777,963 |
59 |
|||||||||
| 36XX | Non-controlling interest | 6(27) | 662,270 |
4 |
122,283 |
1 |
124,739 |
1 |
|||||||
| 3XXX | Total equity | 9,497,784 |
63 |
9,032,993 |
59 |
8,902,702 |
60 |
||||||||
| Significant contingent liabilities | 9 | ||||||||||||||
| and unrecognised contract | |||||||||||||||
| commitments | |||||||||||||||
| 3X2X | Total liabilities and equity | $ |
15,004,752 |
100 |
$ |
15,227,132 |
100 |
$ |
14,794,744 |
100 |
The accompanying notes are an integral part of these consolidated financial statements.
~4~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Expressed in thousands of New Taiwan dollars, except earnings (loss) per share amount)
(UNAUDITED)
| Three-month periods ended September 30 | Three-month periods ended September 30 | Three-month periods ended September 30 | Three-month periods ended September 30 | Three-month periods ended September 30 | Nine-month periods ended September 30 | Nine-month periods ended September 30 | Nine-month periods ended September 30 | Nine-month periods ended September 30 | Nine-month periods ended September 30 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| Items | Notes | AMOUNT |
% | AMOUNT | % | AMOUNT |
% | AMOUNT |
% | |||||||
| 4000 | Sales revenue | 6(19) | $ |
2,634,947 |
100 |
$ 2,924,158 |
100 |
$ |
7,769,096 |
100 |
$ |
8,138,234 |
100 |
|||
| 5000 | Operating costs | 6(23)(24) | ( |
2,307,783) ( |
88) ( |
2,467,183 ) ( |
84) ( |
6,699,948) ( |
86) ( |
7,101,054) ( |
87) |
|||||
| 5900 | Net operating margin | 327,164 |
12 |
456,975 |
16 |
1,069,148 |
14 |
1,037,180 |
13 |
|||||||
| Operating expenses | 6(23)(24) | |||||||||||||||
| 6100 | Selling expenses | ( |
16,509) |
- ( |
32,923 ) ( |
1) ( |
53,080) ( |
1) ( |
66,074) ( |
1) |
||||||
| 6200 | General & administrative | |||||||||||||||
| expenses | ( |
81,155) ( |
3) ( |
158,708 ) ( |
5) ( |
256,708) ( |
3) ( |
276,576) ( |
4) |
|||||||
| 6300 | Research and development | |||||||||||||||
| expenses | ( |
204,902) ( |
8) ( |
248,463 ) ( |
9) ( |
688,181) ( |
9) ( |
756,454) ( |
9) |
|||||||
| 6000 | Total operating expenses | ( |
302,566) ( |
11) ( |
440,094 ) ( |
15) ( |
997,969) ( |
13) ( |
1,099,104) ( |
14) |
||||||
| 6900 | Operating profit (loss) | 24,598 |
1 |
16,881 |
1 |
71,179 |
1 ( |
61,924) ( |
1) |
|||||||
| Non-operating income and | ||||||||||||||||
| expenses | ||||||||||||||||
| 7010 | Other income | 6(20) | 34,047 |
1 |
29,563 |
1 |
79,160 |
1 |
66,514 |
1 |
||||||
| 7020 | Other gains and losses | 6(21) | ( |
34,202) ( |
1) |
4,196 |
- ( |
86,045) ( |
1) |
24,281 |
- |
|||||
| 7050 | Finance costs | 6(22) | ( |
6,257) |
- ( |
6,343 ) |
- ( |
19,807) |
- ( |
19,223) |
- |
|||||
| 7000 | Total non-operating | |||||||||||||||
| income and expenses | ( |
6,412) |
- |
27,416 |
1 ( |
26,692) |
- |
71,572 |
1 |
|||||||
| 7900 | Profit before income tax | 18,186 |
1 |
44,297 |
2 |
44,487 |
1 |
9,648 |
- |
|||||||
| 7950 | Income tax expense | 6(25) | ( |
23,850) ( |
1) ( |
15,623 ) ( |
1) ( |
39,956) ( |
1) ( |
20,960) |
- |
|||||
| 8200 | Profit (loss) for the period | ($ |
5,664) |
- |
$ |
28,674 |
1 |
$ |
4,531 |
- ($ |
11,312) |
- |
||||
| Other comprehensive income | ||||||||||||||||
| Components of other | ||||||||||||||||
| comprehensive income that will | ||||||||||||||||
| be reclassified to profit or loss | ||||||||||||||||
| 8361 | Currency translation | |||||||||||||||
| differences of foreign | ||||||||||||||||
| operations | $ |
54,089 |
2 ($ |
291,594 ) ( |
10) ($ |
318,431) ( |
4) ($ |
557,638) ( |
7) |
|||||||
| 8370 | Share of other comprehensive | |||||||||||||||
| income (loss) of associates and | ||||||||||||||||
| joint ventures accounted for | ||||||||||||||||
| uner equity method | - |
- ( |
4,856 ) |
- |
1,520 |
- ( |
10,219) |
- |
||||||||
| 8399 | Income tax relating to the | 6(25) | ||||||||||||||
| components of other | ||||||||||||||||
| comprehensive income | ( |
9,722) |
- |
50,286 |
2 |
53,977 |
1 |
96,359 |
1 |
|||||||
| 8360 | Components of other | |||||||||||||||
| comprehensive income | ||||||||||||||||
| (loss) that will be | ||||||||||||||||
| reclassified to profit or loss | 44,367 |
2 ( |
246,164 ) ( |
8) ( |
262,934) ( |
3) ( |
471,498) ( |
6) |
||||||||
| 8300 | Total other comprehensive | |||||||||||||||
| income (loss) for the period | $ |
44,367 |
2 ($ |
246,164 ) ( |
8) ($ |
262,934) ( |
3) ($ |
471,498) ( |
6) |
|||||||
| 8500 | Total comprehensive income | |||||||||||||||
| (loss) for the period | $ |
38,703 |
2 ($ |
217,490 ) ( |
7) ($ |
258,403) ( |
3) ($ |
482,810) ( |
6) |
|||||||
| Profit (loss), attributable to: | ||||||||||||||||
| 8610 | Owners of the parent | ($ |
10,385) |
- |
$ |
12,113 |
- |
$ |
4,177 |
- ($ |
34,388) |
- |
||||
| 8620 | Non-controlling interest | 4,721 |
- |
16,561 |
1 |
354 |
- |
23,076 |
- |
|||||||
| Profit (loss) for the period | ($ |
5,664) |
- |
$ |
28,674 |
1 |
$ |
4,531 |
- ($ |
11,312) |
- |
|||||
| Comprehensive (loss) income | ||||||||||||||||
| attributable to: | ||||||||||||||||
| 8710 | Owners of the parent | $ |
37,077 |
2 ($ |
233,402 ) ( |
8) ($ |
259,359) ( |
3) ($ |
504,846) ( |
6) |
||||||
| 8720 | Non-controlling interest | 1,626 |
- |
15,912 |
1 |
956 |
- |
22,036 |
- |
|||||||
| Total comprehensive income | ||||||||||||||||
| (loss) for the period | $ |
38,703 |
2 ($ |
217,490 ) ( |
7) ($ |
258,403) ( |
3) ($ |
482,810) ( |
6) |
|||||||
| 9750 | Basic (loss) earnings per | 6(26) | ||||||||||||||
| share | ($ |
0.04) |
$ |
0.05 |
$ |
0.02 ($ |
0.13) |
|||||||||
| 9850 | Diluted (loss) earnings per | 6(26) | ||||||||||||||
| share | ($ |
0.04) |
$ |
0.05 |
$ |
0.02 ($ |
0.13) |
The accompanying notes are an integral part of these consolidated financial statements.
~5~
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Expressed in thousands of New Taiwan dollars)
(UNAUDITED)
| F | or the nine-month period ended | Notes | Equity att | ributable to owners of | the parent | the parent | Non-controlling interest |
Total equity | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common stock | Capital surplus | Retained Earnings | Other equityinterest | Treasury stocks | Total | ||||||||||
| Legal reserve | Special reserve | Unappropriated retained earnings |
Currency translation differences of foreign operations |
Other equity - others |
|||||||||||
| 6(17) 6(16)(17) 6(13)(16)(18) 6(13)(16)(18) 6(27) 6(18) 6(17) 6(17) 6(13)(16)(18) 6(13)(16)(18) 6(27) 6(18) |
$ 2,726,938---15,600(2,750 )----$ 2,739,788$ 2,739,788--1,300(2,400 )----$ 2,738,688 |
$ 1,975,772-(134,140 )23625,713(4,620 )(47 )---$ 1,862,914$ 1,862,914--2,404(3,957 )369,789---$ 2,231,150 |
$ 1,347,01027,364--------$ 1,374,374$ 1,374,3745,380-------$ 1,379,754 |
$142,456---------$142,456$142,456--------$142,456 |
$3,047,283(27,364 )(134,140 )----(34,388 )--$2,851,391$2,946,092(5,380 )(215,596 )---4,177--$2,729,293 |
$477,768-------(470,458 ) -$7,310$35,009------(263,536 ) -($228,527 ) |
($63,121 ) --26,187(41,313 ) 7,370----($70,877 ) ($60,530 ) --26,2666,357----($27,907 ) |
($129,393 ) ---------($129,393 ) ($129,393 ) --------($129,393 ) |
$ 9,524,713-(268,280 ) 26,423--(47 ) (34,388 ) (470,458 ) -$ 8,777,963$ 8,910,710-(215,596 ) 29,970-369,7894,177(263,536 ) -$ 8,835,514 |
$104,139-----4723,076(1,040 ) (1,483 ) $124,739$122,283----(369,789 ) 354602908,820$662,270 |
$9,628,852-(268,280 )26,423---(11,312 )(471,498 )(1,483 )$8,902,702$9,032,993-(215,596 )29,970--4,531(262,934 )908,820$9,497,784 |
||||
F |
September 30, 2016 Balance at January 1, 2016 Appropriation of 2015 earnings Legal reserve Cash dividends and capital surplus used to issue cash to shareholders Share-based payment transactions Restricted stock Retirement of employee restricted shares Difference between consideration and carrying amount of subsidiaries acquired Profit (loss) for the period Other comprehensive loss for the period Non-controlling interest Balance at September 30, 2016 or the nine-month period ended |
||||||||||||||
September 30, 2017 Balance at January 1, 2017 Appropriation of 2016 earnings Legal reserve Cash dividends Share-based payment transactions Retirement of employee restricted shares Changes in ownership interests in subsidiaries Profit for the period Other comprehensive income (loss) for the period Non-controlling interest Balance at September 30, 2017 |
The accompanying notes are an integral part of these consolidated financial statements.
~6~
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Expressed in thousands of New Taiwan dollars)
(UNAUDITED)
CASH FLOWS FROM OPERATING ACTIVITIES Profit before tax Adjustments Adjustments to reconcile profit (loss) Depreciation Amortisation Provision for doubtful accounts Net gain on financial assets at fair value through profit or loss Interest expense Interest income Cash dividends income Share-based payment compensation cost Loss on disposal of investment Gain on disposal of property, plant and equipment Changes in operating assets and liabilities Changes in operating assets Financial assets at fair value through profit or loss - current Notes receivable Accounts receivable Other receivables Inventories Prepayments Other current assets Changes in operating liabilities Notes payable Accounts payable Other payables Provisions for liabilities Other current liabilities Other non-current liabilities Cash inflow (outflow) generated from operations Interest received Cash dividends received Interest paid Income tax paid Net cash flows from (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES Acquisition of financial assets at cost Loss on disposal of accounted for under the equity method Proceeds from capital reduction of financial assets at cost Acquisition of property, plant and equipment Proceeds from disposal of property, plant and equipment Increase in intangible assets Decrease in deposits-out Net cash flows from (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES Increase (decrease) in short-term borrowings Decrease in deposits-in Employee stock options exercised Cash dividentds Changes in non-controlling interest Net cash flows from financing activities Effect of exchange rate Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period |
Nine-month periods ended September 30 Notes 2017 2016 $44,487 $9,6486(7)(8)(23) 205,604261,2176(9)(10)(23) 10,58311,3076(3) (571 )9,189440 (1,360 )6(22) 19,80719,2236(20) (54,352 ) (39,888 )6(20) (3,113 ) (610 )6(13)(24) 26,26626,4236(21) 4,206-6(21) (460 ) (3,189 )(168,868 ) (424,046 )34616,692612,295 (136,767 )3,522 (3,141 )296,890 (356,127 )41,816 (132,655 )(4,080 ) (13,979 )-2,010(498,944 ) (163,208 )(31,147 ) (6,213 )(35,990 )8,585(9,545 ) (156,077 )145 392 459,337 (1,072,574 )51,37846,6673,113610(20,061 ) (19,032 )(61,947 ) (41,972 )431,820 (1,086,301 )(13,470 ) (14,800 )123,572-2,758-6(29) (82,131 ) (91,138 )21,25520,3176(29) (6,163 ) (6,356 )13,433 6,624 59,254 (85,353 )6(11) (49,000 )495,00013,9643,5743,704-(215,596 )-6(27) 908,820 (1,483 )661,892 497,091 (245,110 ) (345,188 )907,856 (1,019,751 )6(1) 4,849,989 5,741,973 6(1) $5,757,845 $4,722,222 |
|---|---|
The accompanying notes are an integral part of these consolidated financial statements.
~7~
ALTEK CORPORATION AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017 AND 2016
(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)
(Unaudited)
1. HISTORY AND ORGANIZATION
Altek Corporation (the “Company”) was incorporated as a company limited by shares under the provisions of the Company Law of the Republic of China (R.O.C.). The Company and its subsidiaries (collectively referred herein as the “Group”) are primarily engaged in the development, manufacturing and sale of digital image technology application, and related export and import trade.
The Company was listed in the Taiwan Stock Exchange on December 24, 2002, as approved by the TaiTz (91) Letter No. 024976 of the former Securities and Futures Commission, Ministry of Finance, R.O.C., dated September 27, 2002.
2. THE DATE OF AUTHORIZATION FOR ISSUANCE OF THE CONSOLIDATED FINANCIAL
STATEMENTS AND PROCEDURES FOR AUTHORIZATION
These consolidated financial statements were authorized for issuance by the Board of Directors on November 13, 2017.
3. APPLICATION OF NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS
- (1) Effect of the adoption of new issuances of or amendments to International Financial Reporting Standards (“IFRSs”) as endorsed by the Financial Supervisory Commission (“FSC”) New standards, interpretations and amendments endorsed by the FSC effective from 2017 are as follows:
| follows: | |
|---|---|
| New Standards,Interpretations andAmendments | Effective date by International Accounting StandardsBoard |
| Investment entities: applying the consolidation exception (amendments to IFRS 10, IFRS 12 and IAS 28) Accounting for acquisition of interests in joint operations (amendments to IFRS 11) IFRS 14, ‘Regulatory deferral accounts’ Disclosure initiative (amendments to IAS 1) Clarification of acceptable methods of depreciation and amortisation (amendments to IAS 16 and IAS 38) Agriculture: bearer plants (amendments to IAS 16 and IAS 41) Defined benefit plans: employee contributions (amendments to IAS 19) Equity method in separate financial statements (amendments to IAS Recoverable amount disclosures for non-financial assets (amendments to IAS 36) |
January 1, 2016 January 1, 2016 January 1, 2016 January 1, 2016 January 1, 2016 January 1, 2016 July 1, 2014 January 1, 2016 January 1, 2014 |
~8~
| New Standards,Interpretations andAmendments | Effective date by International Accounting StandardsBoard |
|---|---|
| Novation of derivatives and continuation of hedge accounting (amendments to IAS 39) IFRIC 21, ‘Levies’ Improvements to IFRSs 2010-2012 Improvements to IFRSs 2011-2013 Improvements to IFRSs 2012-2014 |
January 1, 2014 January 1, 2014 July 1, 2014 July 1, 2014 January 1, 2016 |
The above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment. (2) Effect of new issuances of or amendments to IFRSs as endorsed by the FSC but not yet adopted by the Group
New standards, interpretations and amendments endorsed by the FSC effective from 2018 are as follows:
| follows: | |
|---|---|
| New Standards,Interpretations andAmendments Classification and measurement of share-based payment transactions (amendmentsto IFRS 2) Applying IFRS 9 ‘Financial instruments’ with IFRS 4 ‘Insurance contracts’ (amendments to IFRS 4) IFRS 9, ‘Financial instruments’ IFRS 15, ‘Revenue from contracts with customers’ Clarifications to IFRS 15, ‘Revenue from contracts with customers’ (amendments to IFRS 15) Disclosure initiative (amendments to IAS 7) Recognition of deferred tax assets for unrealised losses (amendments to IAS 12) Transfers of investment property (amendments to IAS 40) IFRIC 22, ‘Foreign currency transactions and advance consideration’ Annual improvements to IFRSs 2014-2016 cycle- Amendments to IFRS 1, ‘First-time adoption of International Financial Reporting Standards’ Annual improvements to IFRSs 2014-2016 cycle- Amendments to IFRS 12, ‘Disclosure of interests in other entities’ Annual improvements to IFRSs 2014-2016 cycle- Amendments to IAS 28, ‘Investments in associates and joint ventures’ |
Effective date by International Accounting StandardsBoard |
| January 1, 2018 January 1, 2018 January 1, 2018 January 1, 2018 January 1, 2018 January 1, 2017 January 1, 2017 January 1, 2018 January 1, 2018 January 1, 2018 January 1, 2017 January 1, 2018 |
Except for the following, the above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment. The quantitative impact will be disclosed when the assessment is complete.
~9~
-
A. IFRS 9, ‘Financial instruments’
-
(a) Classification of debt instruments is driven by the entity’s business model and the contractual cash flow characteristics of the financial assets, which would be classified as financial asset at fair value through profit or loss, financial asset measured at fair value through other comprehensive income or financial asset measured at amortised cost. Equity instruments would be classified as financial asset at fair value through profit or loss, unless an entity makes an irrevocable election at inception to present in other comprehensive income subsequent changes in the fair value of an investment in an equity instrument that is not held for trading.
-
(b) The impairment losses of debt instruments are assessed using an ‘expected credit loss’ approach. An entity assesses at each balance sheet date whether there has been a significant increase in credit risk on that instrument since initial recognition to recognise 12-month expected credit losses or lifetime expected credit losses (interest revenue would be calculated on the gross carrying amount of the asset before impairment losses occurred); or if the instrument that has objective evidence of impairment, interest revenue after the impairment would be calculated on the book value of net carrying amount (i.e. net of credit allowance). The Company shall always measure the loss allowance at an amount equal to lifetime expected credit losses for trade receivables that do not contain a significant financing component.
-
B. IFRS 15, ‘Revenue from contracts with customers’
-
IFRS 15, ‘Revenue from contracts with customers’ replaces IAS 11 ‘Construction contracts’, IAS 18 ‘Revenue’ and relevant interpretations. According to IFRS 15, revenue is recognised when a customer obtains control of promised goods or services. A customer obtains control of goods or services when a customer has the ability to direct the use of, and obtain substantially all of the remaining benefits from, the asset.
-
The core principle of IFRS 15 is that an entity recognises revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. An entity recognises revenue in accordance with that core principle by applying the following steps:
-
Step 1: Identify contracts with customer.
-
Step 2: Identify separate performance obligations in the contract(s).
-
Step 3: Determine the transaction price.
Step 4: Allocate the transaction price.
Step 5: Recognise revenue when the performance obligation is satisfied.
Further, IFRS 15 includes a set of comprehensive disclosure requirements that requires an entity to disclose sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Under IFRS 15, depending on the nature of licences, they are either (1) a promise to provide a right to access to an entity’s intellectual property as it exists throughout the licence period, or (2) a promise to provide a right to use an entity’s intellectual property as it exists at the point in time
~10~
when the licence is granted.
Licences that meet all of the following criteria provide access to an entity’s intellectual property, and revenue is recognised based on the performance obligation's progress towards completion:
-
the contract requires, or the customer reasonably expects, that the entity will undertake activities that significantly affect the intellectual property to which the customer has rights;
-
the rights granted by the licence directly expose the customer to any positive or negative effects of the entity’s activities identified above; and
-
those activities do not result in the transfer of a good or service to the customer as those activities occur.
If licences cannot meet all criteria listed above, the entity provides a right to use the entity's intellectual property. Revenue shall be recognised at the point in time at which the licence is granted to the customer.
C. Amendments to IFRS 15, ‘Clarifications to IFRS 15 Revenue from Contracts with Customers’ The amendments clarify how to identify a performance obligation (the promise to transfer a good or a service to a customer) in a contract; determine whether a company is a principal (the provider of a good or service) or an agent (responsible for arranging for the good or service to be provided); and determine whether the revenue from granting a licence should be recognised at a point in time or over time. In addition to the clarifications, the amendments include two additional reliefs to reduce cost and complexity for a company when it first applies the new Standard.
(3) IFRSs issued by IASB but not yet endorsed by the FSC
New standards, interpretations and amendments issued by IASB but not yet included in the IFRSs endorsed by the FSC are as follows:
| endorsed by the FSC are as follows: | |
|---|---|
| New Standards,Interpretations and Amendments | Effective date by International Accounting Standards Board |
| Prepayment features with negative compensation (amendments to IFRS9) Sale or contribution of assets between an investor and its associate or joint venture (amendments to IFRS 10 and IAS 28) IFRS 16, ‘Leases’ IFRS 17, ‘Insurance contracts’ Long-term interests in accociates and joint ventures (amendments to IFRIC 23, ‘Uncertainty over income tax treatments’ |
January 1, 2019 To be determined by International Accounting Standards Board January 1, 2019 January 1, 2021 January 1, 2019 January 1, 2019 |
Except for the following, the above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment. The quantitative impact will be disclosed when the assessment is complete.
~11~
IFRS 16, ‘Leases’
IFRS 16, ‘Leases’, replaces IAS 17, ‘Leases’ and related interpretations and SICs. The standard requires lessees to recognise a 'right-of-use asset' and a lease liability (except for those leases with terms of 12 months or less and leases of low-value assets). The accounting stays the same for lessors, which is to classify their leases as either finance leases or operating leases and account for those two types of leases differently. IFRS 16 only requires enhanced disclosures to be provided by lessors.
4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the periods presented, unless otherwise stated.
(1) Compliance statement
-
A. The consolidated financial statements of the Group have been prepared in accordance with the “Rules Governing the Preparation of Financial Statements by Securities Issuers” and IAS 34, ‘Interim Financial Reporting’ as endorsed by the FSC.
-
B. The consolidated financial statements should be read together with the 2016 consolidated financial statements.
(2) Basis of preparation
-
A. Except for the following items, the consolidated financial statements have been prepared under the historical cost convention:
-
(a) Financial assets and financial liabilities (including derivative instruments) at fair value through profit or loss.
-
(b) Defined benefit liabilities recognised based on the net amount of pension fund assets less present value of defined benefit obligation.
-
B. The preparation of financial statements in conformity with International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations as endorsed by the FCS (collectively referred herein as the “IFRSs” ) requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Group’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in Note 5.
(3) Basis of consolidation
-
A. Basis for preparation of consolidated financial statements:
-
Basis for preparation of consolidated financial statements is consistent with the 2016 consolidated financial statements.
-
B. Subsidiaries included in the consolidated financial statements:
~12~
| Name of Investor | Name of Subsidiaries | Main Business Activities | Ownership (%) | Note | ||
|---|---|---|---|---|---|---|
| September 30,2017 | December 31,2016 | September 30,2016 | ||||
| Altek Corporation Altek International Investment Co., Ltd. Investments and general business operations 100 " Altek Japan Corporation Sales and design of optical instruments 100 " Altek Investment Co., Ltd. Investments 100 " Altek Autotronics Corporation Research design, manufacture and sales of car electronic components - " Altek International Holding (BVI) Co.,Ltd. Investments and general business operations 100 Altek International Investment Co., Ltd. Altek Lab Inc. Design service 100 " Altek Optical (Cayman) Co., Ltd. Investments and general business operations 100 " Altek Semiconductor (Cayman) Co., Ltd. Investments and general business operations 50 Note 2 Altek (Kunshan) Co., Ltd. Manufacture and sales of digital still camera and its accessories 100 Note 2 Altek EMS (Kunshan) Co., Ltd. Manufacture and sales of related engineering services 100 Note 2 Altek Precision (Kunshan) Co., Ltd. Manufacture and sales of digital camera parts 100 Note 2 Altek Trading (Shanghai) Limited Wholesale, import and export of related electronic and their associated accessories 100 Note 3 Altek Biotechnology Corporation Research and development, manufacture and sales of biotechnology 100 Altek Semiconductor (Cayman) Co., Ltd. Altek Semiconductor Corporation Research design and sales of ASIC 100 " Altek Semiconductor (Shanghai) Co., Ltd. Imaging technologies, electronic software and hardware development, IC design and development, technology service, and wholesale, import and export of related products. 100 Note 2 Altek Optical Technology (Kunshan) Co., Ltd. Manufacture and sales of related electronic services and its accessories and optical components 100 Note 1: The Group did not participate in the subsidiary’s capital increase, thus, the share ownership was decreased. Note 2: Invested by Leading Tech. Co., Ltd., Toptek Investment Cayman Co., Ltd., Altek Imaging Technology (Cayman) Co., Ltd., Altek Trading (Cayman) Co., Ltd., Altek Optical Technology (Cayman) Co., Ltd. , which are wholly owned by Altek International Investment Co., Ltd. Note 3: Invested by Altek Biotechnology Holding (Cayman) Co., Ltd., which is wholly owned by Altek International Holding (BVI) Co., Ltd. Note 5: It was invested by Altek Semiconductor (Cayman) Co., Ltd. and was incorporated in January 2017. Note 6: On June 30, 2017, Altek Corporation consummated a short-form merger with Altek Autotronics Corporation and the former is the surviving company. Note 7: As the subsidiaries do not meet the definition of significant subsidiaries, their financial statements as of September 30, 2017 and 2016 were not reviewed by independent acc Note 4: In June 2016, the Group’s investment restructuring transferred the share holding of Altek Biotechnology Corporation to Altek Biotechnology Holding (Cayman) Co., Ltd. , which is a subsidiary of Altek International Holding (BVI) Co., Ltd. |
100 100 100 100 100 100 100 71.43 100 100 100 100 100 100 - 100 ountants. |
100 100 100 100 100 100 100 71.43 100 100 100 100 100 100 - 100 |
- Note 7 Note 7 Note 6 Note 7 Note 4 Note 7 Note 7 Note 7 Note 1 Note 7 - Note 7 Note 7 Note 7 Note 4 Note 7 Note 7 Note 5 Note 7 Note 7 |
~13~
-
C. Subsidiaries not included in the consolidated financial statements: None.
-
D. Adjustments for subsidiaries with different balance sheet dates: None.
-
E. Significant restrictions: None.
-
F. Subsidiaries that have non-controlling interests that are material to the Group: None.
(4) Employee benefits
Pension cost for the interim period is calculated on a year-to-date basis by using the pension cost rate derived from the actuarial valuation at the end of the prior financial year, adjusted for significant market fluctuations since that time and for significant curtailments, settlements, or other significant one-off events. Also, the related information is disclosed accordingly.
(5) Income tax
The interim period income tax expense is recognized based on the estimated average annual effective income tax rate expected for the full financial year applied to the pretax income of the interim period, and the related information is disclosed accordingly.
5. CRITICAL ACCOUNTING JUDGEMENTS, ESTIMATES AND KEY SOURCES OF ASSUMPTION UNCERTAINTY
The preparation of these consolidated financial statements requires management to make critical judgements in applying the Group’s accounting policies and make critical assumptions and estimates concerning future events. Assumptions and estimates may differ from the actual results and are continually evaluated and adjusted based on historical experience and other factors. Such assumptions and estimates have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year; and the related information is addressed below:
(1) Critical judgements in applying the Group’s accounting policies: None.
(2) Critical accounting estimates and assumptions:
- Evaluation of inventories
As inventories are stated at the lower of cost and net realisable value, the Group must determine the net realisable value of inventories on balance sheet date using judgements and estimates. Due to the rapid technology innovation, the Group evaluates the amounts of obsolete inventories on balance sheet date, and writes down the cost of inventories to the net realisable value. Such an evaluation of inventories is principally based on the demand for the products within the specified period in the future. Therefore, there might be material changes to the evaluation.
As of September 30, 2017, the carrying amount of inventories was $1,141,366.
~14~
6. DETAILS OF SIGNIFICANT ACCOUNTS
(1) Cash and cash equivalents
| Cash and cash equivalents | |||
|---|---|---|---|
| Cash on hand Checking accounts and demand deposits Time deposits Total |
September30,2017 1,280 $ 213,759 5,542,806 5,757,845 $ |
December31,2016 1,319 $ 123,931 4,724,739 4,849,989 $ |
September30,2016 |
| 1,570 $ 114,624 4,606,028 |
|||
| 4,722,222 $ |
-
A. The Group transacts with a variety of financial institutions all with high credit quality to disperse credit risk, so it expects that the probability of counterparty default is remote.
-
B. The Group has no cash and cash equivalents pledged to others.
(2) Financial assets at fair value through profit or loss
| Items Current items: Financial assets held for trading Valuation adjustment Total |
September30,2017 859,317 $ 2,820 862,137 $ |
December31,2016 690,449 $ 3,260 693,709 $ |
September30,2016 |
|---|---|---|---|
| 849,079 $ 3,859 |
|||
| 852,938 $ |
The Group recognized net gain of $712 and $549 for the three-month periods ended September 30, 2017 and 2016, respectively, and net gain of $1,880 and $1,835 for the nine-month periods ended September 30, 2017 and 2016, respectively.
(3) Accounts receivable
| Accounts receivable | |||||||
|---|---|---|---|---|---|---|---|
| September30,2017 | December31,2016 | September30,2016 | |||||
| Accounts receivable | 2,152,196 $ |
2,792,622 $ |
$ | 2,331,361 |
|||
| Less: Allowance for bad debts | ( | 8,851) |
( | 9,477) |
( | 9,584) |
|
| 2,143,345 $ |
2,783,145 $ |
$ | 2,321,777 | ||||
| A. The credit quality of accounts receivable that were neither past due nor | impaired was in t | ||||||
| following categories based | on the Group’s Credit Quality Control Policy: | ||||||
| September30,2017 | December31,2016 | September30,2016 | |||||
| Group 1 | 2,013,026 $ |
2,734,047 $ |
$ | 2,291,659 |
|||
| Group 2 | 122,969 | 36,239 | 19,301 | ||||
| 2,135,995 $ |
2,770,286 $ |
$ | 2,310,960 |
- A. The credit quality of accounts receivable that were neither past due nor impaired was in the following categories based on the Group’s Credit Quality Control Policy:
Note:
Group 1: Including domestic and foreign listed companies and their affiliated companies. Group 2: Others.
~15~
B. The ageing analysis of accounts receivable that were past due but not impaired is as follows:
| Up to 30 days 31 to 90 days 91 to 180 days Over 181 days |
September30,2017 - $ - - 7,350 7,350 $ |
December31,2016 1,647 $ 6,291 - 4,921 12,859 $ |
September30,2016 |
|---|---|---|---|
| 2,120 $ 4,585 4,112 - |
|||
| 10,817 $ |
The above ageing analysis was based on past due date.
C. Movements in the provision for impairment of accounts receivable are as follows:
| Individualprovision Group provision Total At January 1 9,477 $ - $ 9,477 $ Reversal of impairment 571) ( - 571) ( Effects of foreign exchange 55) ( - 55) ( At September 30 8,851 $ - $ 8,851 $ 2017 Individualprovision Group provision Total At January 1 - $ 534 $ 534 $ Provision for impairment 9,723 534) ( 9,189 Effects of foreign exchange 139) ( - 139) ( At September 30 9,584 $ - $ 9,584 $ 2016 |
2017 | ||
|---|---|---|---|
| Group provision Total - $ 9,477 $ - 571) ( - 55) ( - $ 8,851 $ 2016 |
Total | ||
| 8,851 $ |
|||
| Total | |||
| 9,584 $ |
D. The Group does not hold any collateral as security.
(4) Inventories
September 30, 2017
| September30,2017 | ||
|---|---|---|
| Raw materials Work-in-process Finished goods Total Raw materials Work-in-process Finished goods Total |
Allowance for Cost valuation loss 767,835 $ 51,560) ($ 234,147 19,794) ( 222,695 11,957) ( 1,224,677 $ 83,311) ($ December31,2016 |
Bookvalue |
| 716,275 $ 214,353 210,738 |
||
| 1,141,366 $ |
||
| Allowance for Cost valuation loss 828,083 $ 59,076) ($ 203,734 24,153) ( 559,346 36,963) ( 1,591,163 $ 120,192) ($ |
Bookvalue | |
| 769,007 $ 179,581 522,383 |
||
| 1,470,971 $ |
~16~
September 30, 2016
| Allowance | for | |||||||
|---|---|---|---|---|---|---|---|---|
| Cost | valuation loss | Bookvalue | ||||||
| Raw materials | $ | 830,204 |
96,052) ($ |
$ | 734,152 |
|||
| Work-in-process | 294,460 | ( | 26,063) |
268,397 | ||||
| Finished goods | 381,208 | ( | 54,174) |
327,034 | ||||
| Total | $ | 1,505,872 | 176,289) ($ |
$ | 1,329,583 | |||
| The cost of inventories recognised as expense for the periods: | ||||||||
| For the three-month period | For the | three-month period | ||||||
| endedSeptember30,2017 | endedSeptember30,2016 | |||||||
| Cost of goods sold | $ | 2,332,347 |
$ | 2,471,188 |
||||
| Reversal of decline in market value | ( | 24,564) |
( | 4,005) |
||||
| Total | $ | 2,307,783 | $ | 2,467,183 | ||||
| For the nine-month period | For the | nine-month period | ||||||
| ended September30,2017 | ended | September30,2016 | ||||||
| Cost of goods sold | $ | 6,777,071 |
$ | 6,967,354 |
||||
| (Reversal of) loss on decline in market | ||||||||
| value | ( | 77,123) |
133,700 | |||||
| Total | $ | 6,699,948 | $ | 7,101,054 | ||||
| Financial assets measured at cost | ||||||||
| Items | September30,2017 | December31, | 2016 | September30,2016 | ||||
| Non-current items: | ||||||||
| Unlisted stocks | $ | 170,615 |
160,430 $ |
$ | 168,814 |
|||
| Less: Accumulated impairment | ( | 12,596) |
( | 12,596) |
( | 12,596) |
||
| Total | $ | 158,019 | 147,834 $ |
$ | 156,218 |
(5) Financial assets measured at cost
-
A. As the Group’s investment in unlisted stocks are not traded in an active market, and no sufficient industry information of companies similar to these stocks financial information can be obtained, the fair value of the investment in unlisted stocks cannot be measured reliably. The Group classified those stocks as ‘financial assets measured at cost’.
-
B. No impairment loss was recognized for the financial assets measured at cost for the three-month and nine-month periods ended September 30, 2017 and 2016.
-
C. As of September 30, 2017, December 31, 2016 and September 30, 2016, no financial assets measured at cost held by the Group were pledged to others.
~17~
(6) Investments accounted for under the equity method
| September | 30,2017 | December | 31,2016 | September | 30,2016 | ||||
|---|---|---|---|---|---|---|---|---|---|
| JinJing Optical Technology Co., | $ | 44,028 |
$ | 44,028 |
$ | 44,028 |
|||
| Ltd. | |||||||||
| Phoenix Optical (Shanghai) Co., | |||||||||
| Ltd. | - | 139,971 | 141,459 | ||||||
| 44,028 | 183,999 | 185,487 | |||||||
| Less: Accumulated impairment | |||||||||
| loss | ( | 44,028) | ( | 57,242) |
( | 57,242) | |||
| $ | - | $ | 126,757 | $ | 128,245 |
-
A. On May 8, 2017, Phoenix Optical (Shanghai) Co., Ltd. has completed its liquidation.
-
B. The carrying amount of the Group’s interests in all individually immaterial associates and the Group’s share of the operating results are summarized below:
As of September 30, 2017, December 31, 2016 and September 30, 2016, the carrying amount of the Group’s individually immaterial associates amounted to $0, $126,757 and $128,245, respectively.
| respectively. | |||||
|---|---|---|---|---|---|
| For the nine-month period | For the nine-month period | ||||
| endedSeptember30,2017 | endedSeptember30,2016 | ||||
| Loss for the period from continuing | ($ | 21,555) |
($ | 85,481) |
|
| operations | |||||
| Other comprehensive income (loss) | |||||
| -net of tax | 3,050 | ( | 1,762) |
||
| Total comprehensive loss | ($ | 18,505) | ($ | 87,243) |
(Blank below)
~18~
(7) Property, plant and equipment
| At January 1, 2017 Cost Accumulated depreciation For the nine-month period ended September 30, 2017 Opening net book amount Additions Disposals Reclassifications Depreciation charge Net exchange differences Closing net book amount At September 30, 2017 Cost Accumulated depreciation |
Land 1,042,216 $ - 1,042,216 $ 1,042,216 $ - - - - - 1,042,216 $ 1,042,216 $ - 1,042,216 $ |
Buildings and structures Machinery Test equipment 3,522,603 $ 1,443,305 $ 199,899 $ 643,506) ( 840,003) ( 178,950) ( 2,879,097 $ 603,302 $ 20,949 $ 2,879,097 $ 603,302 $ 20,949 $ 83,646 545 818 - 19,977) ( 186) ( 170,019) ( - - 65,314) ( 82,347) ( 7,780) ( 35,866) ( 13,204) ( 254) ( 2,691,544 $ 488,319 $ 13,547 $ 3,355,493 $ 1,370,158 $ 180,397 $ 663,949) ( 881,839) ( 166,850) ( 2,691,544 $ 488,319 $ 13,547 $ |
|
|---|---|---|---|
~19~
| At January 1, 2016 Cost Accumulated depreciation For the nine-month period ended September 30, 2016 Opening net book amount Additions Disposals Reclassifications Depreciation charge Net exchange differences Closing net book amount At September 30, 2016 Cost Accumulated depreciation |
Land 1,042,216 $ - 1,042,216 $ 1,042,216 $ - - - - - 1,042,216 $ 1,042,216 $ - 1,042,216 $ |
Buildings and structures Machinery Test equipment 3,717,659 $ 1,868,136 $ 201,217 $ 584,318) ( 1,063,689) ( 177,229) ( 3,133,341 $ 804,447 $ 23,988 $ 3,133,341 $ 804,447 $ 23,988 $ 131 380 9,543 - 16,165) ( - - - 3,006 69,884) ( 98,715) ( 11,653) ( 143,295) ( 51,620) ( 1,222) ( 2,920,293 $ 638,327 $ 23,662 $ 3,545,283 $ 1,449,397 $ 203,046 $ 624,990) ( 811,070) ( 179,384) ( 2,920,293 $ 638,327 $ 23,662 $ |
|
|---|---|---|---|
For the nine-month periods ended September 30, 2017 and 2016, there was no capitalisation of borrowing interests attributable to the property, plant and equipment and the Group did not pledge any fixed asset as collateral.
~20~
(8) Investment acuisition-Buildings and structures
| Investment acuisition-Buildings and structures | ||||
|---|---|---|---|---|
| For the nine-month period | For the nine-month period | |||
| ended September30,2017 | ended September30,2016 | |||
| At January 1 | ||||
| Cost | $ | - |
$ | - |
| Accumulated depreciation | - | - | ||
| $ | - | $ | - | |
| For the nine-month period ended September 30 | ||||
| Opening net book amount | $ | - |
$ | - |
| Additions-from acquisitions | 9,000 | - | ||
| Reclassifications | 199,062 | - | ||
| Depreciation charge | ( | 2,521) |
- | |
| Closing net book amount | $ | 205,541 | $ | - |
| At September 30 | ||||
| Cost | $ | 245,710 |
$ | - |
| Accumulated depreciation | ( | 40,169) |
- | |
| $ | 205,541 | $ | - |
- A. Rental income from investment property and direct operating expenses arising from investment property are shown below:
| roperty are shown below: | ||||
|---|---|---|---|---|
| For the nine-month period | For the nine-month period | |||
| ended September30,2017 | ended September30,2016 | |||
| Rental income from investment property | $ | 10,770 | $ | - |
| Direct operating expenses arising from | ||||
| the investment property that generated | $ | 2,851 | $ | - |
| rental income during the period | ||||
| Direct operating expenses arising from | ||||
| the investment property that did not | ||||
| generate rental income during the period | $ | - | $ | - |
-
B. As at September 30, 2017, the fair value of investment property held by the Group amounted to $886,343. The fair value was valuated with the technique that is widely adopted by market participants by referring to substantiating evidence such as transaction price of similar property.
-
C. There was no capitalisation of borrowing interests attributable to investment property.
-
D. The Group did not pledge any investment property as collateral.
~21~
(9) Intangible assets
For the nine-month period For the nine-month period ended September 30, 2017 ended September 30, 2016
| At January 1 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Cost | $ | 129,020 |
$ | 130,369 |
||||
| Accumulated amortisation | ( | 36,103) |
( | 36,656) |
||||
| $ | 92,917 | $ | 93,713 | |||||
| For the nine-month period ended September 30 | ||||||||
| Opening net book amount | $ | 92,917 |
$ | 93,713 |
||||
| Additions | 1,445 | 15,423 | ||||||
| Amortisation charge | ( | 9,901) |
( | 10,557) |
||||
| Net exchange differences | ( | 4,597) |
( | 4,130) |
||||
| Closing net book amount | $ | 79,864 | $ | 94,449 | ||||
| At September 30 | ||||||||
| Cost | $ | 125,431 |
$ | 127,426 |
||||
| Accumulated amortisation | ( | 45,567) |
( | 32,977) |
||||
| $ | 79,864 | $ | 94,449 | |||||
| A. Details of amortisation on intangible assets are as follows: | ||||||||
| For the three-month period | For | the three-month period | ||||||
| endedSeptember | 30,2017 | endedSeptember30,2016 | ||||||
| Operating costs | $ | 1,327 |
$ | 1,396 |
||||
| Operating expense | 1,772 | 2,037 | ||||||
| $ | 3,099 | $ | 3,433 | |||||
| For the nine-month period | For | the nine-month period | ||||||
| endedSeptember | 30,2017 | endedSeptember30,2016 | ||||||
| Operating costs | $ | 3,963 |
$ | 4,497 |
||||
| Operating expense | 5,938 | 6,060 | ||||||
| $ | 9,901 | $ | 10,557 | |||||
| B. The Group has no intangible | assets pledged to others. | |||||||
| (10)Long-term prepaid rents ( shown as‘Other non-current assets’) | ||||||||
| September30,2017 | December31, | 2016 | September30,2016 | |||||
| Land-use right | $ | 33,563 | $ | 34,929 | $ | 35,521 | ||
| The Group recognized amortisation expenses for the three-month periods ended | September 30, 2017 | |||||||
| and 2016 amounting to $229 and $242, and for the nine-month periods ended | September 30, 2017 | |||||||
| and 2016 amounting to $682 and $750, respectively. |
~22~
(11) Short-term borrowings
| Short-term borrowings | |||
|---|---|---|---|
| Type ofborrowings Bank borrowings Unsecured borrowings Type of borrowings Bank borrowings Unsecured borrowings Type of borrowings Bank borrowings Unsecured borrowings |
September30,2017 2,366,000 $ December31,2016 2,415,000 $ September30,2016 2,225,000 $ |
Interestraterange 1% ~1.19% Interest rate range 1.1%~1.2% Interest rate range 1.12%~1.25% |
Collateral |
| None Collateral |
|||
| None Collateral |
|||
| None |
(12) Pensions
-
A. (a) The Company and its domestic subsidiaries have a defined benefit pension plan in accordance with the Labor Standards Law, covering all regular employees’ service years prior to the enforcement of the Labor Pension Act on July 1, 2005 and service years thereafter of employees who chose to continue to be subject to the pension mechanism under the Law. Under the defined benefit pension plan, two units are accrued for each year of service for the first 15 years and one unit for each additional year thereafter, subject to a maximum of 45 units. Pension benefits are based on the number of units accrued and the average monthly salaries and wages of the last 6 months prior to retirement. The Company contributes monthly an amount equal to 2% of the employees’ monthly salaries and wages to the retirement fund deposited with Bank of Taiwan, the trustee, under the name of the independent retirement fund committee.
-
(b) For the aforementioned pension plan, the Group recognized pension costs of $0 and $6 for the three-month periods ended September 30, 2017 and 2016, and of $148 and $404 for the nine-month periods ended September 30, 2017 and 2016, respectively.
-
(c) Expected contributions to the defined benefit pension plans of the Group for the year ending December 31, 2018 amounts to $12.
-
B. (a) Effective July 1, 2005, the Company and its domestic subsidiaries have established a defined contribution pension plan (the “New Plan”) under the Labor Pension Act (the “Act”), covering all regular employees with R.O.C. nationality. Under the New Plan, the Company and its domestic subsidiaries contribute monthly and amount based on 6% of the employees’ monthly salaries and wages to the employees’ individual pension accounts at the Bureau of Labor Insurance. The benefits accrued are paid monthly or in lump sum upon termination of employment. For the three-month periods ended September 30, 2017 and 2016, the Group had recognized pension costs of $7,723 and $8,834, and for the nine-month periods ended September 30, 2017 and 2016, the Group had recognized pension costs of $24,437 and $27,636, respectively, under the above pension scheme.
~23~
- (b) The subsidiaries provided defined contribution plans for its employees. Pursuant to local regulations, such employees and the subsidiaries each make contributions based on a certain percentage based of the salaries and wages to the pension funds. The subsidiaries had recognized pension costs of $6,529 and $7,214 for the three-month periods ended September 30, 2017 and 2016, and of $20,354 and $27,859 for the nine-month periods ended September 30, 2017 and 2016, respectively.
(13) Share-based payment
- A. As of September 30, 2017 and 2016, the Company’s share-based payment arrangements were as follows:
| follows: | ||||
|---|---|---|---|---|
| Type ofarrangement | Grant date | Quantity granted |
Contract period |
Vesting conditions |
| Employee stock options " " " First time issuance of restricted shares to employees " " |
June 13, 2008 October 31, 2008 October 28, 2011 March 21, 2012 November 13, 2015 March 18, 2016 May 5, 2016 |
8,000 1,000 3,000 3,000 2,440 1,190 370 |
9.6 years 9.2 years 9.2 years 8.9 yesrs 3 years 3 years 3 years |
Note 1 Note 1 Note 1 Note 1 Note 2 、Note 3Note 2 、Note 3Note 2 、Note 3 |
-
Note 1: 2 years’ service vest 40%, 3 years’ service vest 70%, 4 years’ service vest 100%.
-
Note 2: The restricted shares were issued at no consideration to the Company’s existing employees whose service years have reached 2 years and 3 years and who achieved the performance requirement. The vested ratio is 50% and 50%, respectively. If employees who are entitled to receive restricted stocks do not meet the vesting conditions, the Company will redeem at no consideration and retire those shares.
-
Note 3: The stocks and dividends distributed to employees during the vesting period shall be given by the Company at no consideration. Employees are not required to return the stocks and dividends if they resign during the vesting period.
~24~
-
B. Details of the share-based payment arrangements are as follows:
-
(a) For the nine-month period ended September 30, 2017 and 2016, the information on the share options and the weighted number of average exercise price of compensation plan employee stock options are as follows:
| Options outstanding at beginning of the period Option expired Options exercised Options outstanding at end of the period Options exercisable at end of the period Approved and not yet issued options at the end of the period |
For the nine-month period ended September 30,2017 |
For the nine-month period ended September 30,2017 |
For the nine-month period ended September 30,2016 |
For the nine-month period ended September 30,2016 |
|
|---|---|---|---|---|---|
| No. of options | Weighted-average exercise price (in dollars)(Note) |
No. of options | Weighted-average exercise price (in dollars)(Note) |
||
| 5,155 1,572) ( 130) ( 3,453 3,453 - |
31.30 $ - 28.49 30.32 30.32 |
5,155 - - 5,155 5,155 - |
32.80 $ - - 31.30 31.30 |
-
Note: The exercise price of stock options was adjusted based on the cash dividends, stock dividends and cash capital reduction per share distributed.
-
(b) The weighted-average stock price of stock options at exercise dates for the three-month period ended September 30, 2017 was $30.35 (in dollars), and for the nine-month period ended September 30, 2017 was $26.91 (in dollars), respectively. No stock options were exercised during the three-month period ended September 30, 2016 and nine-month period ended September 30, 2016.
-
(c) The expiry date and exercise price of stock options outstanding at balance sheet date are as follows:
| follows: | |||||||
|---|---|---|---|---|---|---|---|
| Issue date approved |
Expirydate | September 30,2017 | December | 31,2016 | September 30,2016 | ||
| No. of shares (in thousands) 1,000 - 1,420 1,033 |
Exercise price (in dollars) (Note) $ 29.6 24.8 30.7 30.5 |
No. of shares (in thousands) 1,400 30 2,320 1,405 |
Exercise price (in dollars) (Note) $ 30.6 25.6 31.7 31.5 |
No. of shares (in thousands) 1,400 30 2,320 1,405 |
Exercise price (in dollars) (Note) |
||
| June 13, 2008 October 31, 2008 October 28, 2011 March 21, 2012 |
December 31, 2017 December 31, 2017 December 31, 2020 December 31, 2020 |
$ 30.6 25.6 31.7 31.5 |
- Note: The exercise price of stock options was adjusted based on the cash dividends, stock dividends and cash capital reduction per share distributed.
~25~
- (d) The fair value of stock options granted is measured using the Black-Scholes option-pricing model. Relevant information is as follows:
| Type of arrangement |
Grant date | Stock price (in dollars) |
Exercise price (Note) (in dollars) 29.6 $ 24.8 30.7 30.5 |
Expected price volatility |
Expected option life |
Expected dividends |
Risk- free interest rate |
Fair value per unit (in dollars) |
|---|---|---|---|---|---|---|---|---|
| Employee stock options " " " |
June 13, 2008 October 31, 2008 October 28, 2011 March 21, 2012 |
$ 45.50 32.60 30.65 27.85 |
24.45% 22.11% 30.27% 33.54% |
6 years 6 years 5 years 4.9 years |
1.5% 1.5% 1.4% 1.4% |
2.40% 1.88% 1.18% 1.08% |
10.56 6.54 7.42 7.35 |
-
Note: The exercise price of stock options was adjusted based on the cash dividends, stock dividends and cash capital reduction per share distributed.
-
C. Restricted shares to employees:
-
(a) The information on restricted shares to employees is as follows:
| For the nine-month period | For the nine-month period | For the nine-month period | For the nine-month period | |
|---|---|---|---|---|
| ended September 30, 2017 | ended September 30, 2016 | |||
| (share in thousands) | (share in thousands) | |||
| Outstanding beginning | ||||
| balance | 3,725 | 2,440 | ||
| Shares granted | - | 1,560 | ||
| Restricted shares | ||||
| forfeited-retired | ( | 240) |
( | 190) |
| Restricted shares | ||||
| forfeited-not retired | - | ( | 85) |
|
| Outstanding ending | ||||
| balance | 3,485 | 3,725 |
-
(b) As of September 30, 2017, the Company collected 240 thousand shares of restricted shares because certain employees did not meet the vesting condition, and the change of registration has been completed.
-
D. Expenses incurred on share-based payment transactions are shown below:
| For the three-month period | For the three-month period | |
|---|---|---|
| ended September30,2017 | ended September30,2016 | |
| Equity-settled | 6,809 $ |
8,557 $ |
| For the nine-month period | For the nine-month period | |
| ended September30,2017 | ended September30,2016 | |
| Equity-settled | 26,266 $ |
26,423 $ |
~26~
(14) Provisions
| At January 1, 2017 Additional provisions Rreversed during the period Exchange differences At September 30, 2017 Current Non-current |
September30,2017 49,642 $ 88,436 $ |
$ ( $ December31,2016 52,247 $ 121,819 $ |
Warranty 174,066 33,170 69,160) 2 138,078 September30,2016 28,285 $ 116,178 $ |
|
|---|---|---|---|---|
The Group gives warranties on digital image technology application products sold. Provision for warranty is estimated based on historical warranty data of digital image technology application products.
(15) Share capital
As of September 30, 2017, the Company’s authorized capital was $5,000,000, consisting of 500,000 thousand shares of ordinary stock, and the paid-in capital was $2,738,688 with a par value of $10 (in dollars) per share.
- A. Movements in the number of the Company’s ordinary shares outstanding are as follows:
| (Expressed in | (Expressed in | thousands of | shares) | ||
|---|---|---|---|---|---|
| 2017 | 2016 | ||||
| At January 1 | 269,565 | 268,280 | |||
| Employee stock options exercised | 130 | - | |||
| Issuance of restricted stocks | - | 1,560 | |||
| Retired restricted shares to employees that | |||||
| did not meet the vesting conditions | ( | 240) |
( | 190) |
|
| Redeemed restricted shares to employees that | |||||
| did not meet the vesting conditions | - | ( | 85) |
||
| At September 30 | 269,455 | 269,565 |
~27~
-
B. Treasury shares
-
(a) As of September 30, 2017, December 31, 2016 and September 30, 2016, the reason for share reacquisition and movements in the number of the Company’s treasury shares are as follows:
| Sharesheld by | Reason for reacquisition Repurchase shares under the R.O.C. Company Law Section 186 and the Enterprises Mergers and Acquisitions Act Section 12 To be reissued to employees |
(Expressedinthousands ofshares) | (Expressedinthousands ofshares) |
|---|---|---|---|
| Number ofshares 981 3,433 4,414 |
Bookvalue | ||
| Altek Corporation Altek Corporation |
33,255 $ 96,138 |
||
| 129,393 $ |
-
(b) Pursuant to the R.O.C. Securities and Exchange Act, the number of shares bought back as treasury share should not exceed 10% of the number of the Company’s issued and outstanding shares and the amount bought back should not exceed the sum of retained earnings, paid-in capital in excess of par value and realised capital surplus.
-
(c) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should not be pledged as collateral and is not entitled to dividends before it is reissued.
-
(d) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should be reissued to the employees within three years from the reacquisition date and shares not reissued within the three-year period are to be retired. Treasury shares to enhance the Company’s credit rating and the stockholders’ equity should be retired within six months of acquisition.
-
C. Under the Enterprise Merger and Acquisition Act, in consideration of business strategies and division of services to increase competitiveness and operational performance, the Company decided to spin-off its medical electronics segment amounting to $400,000 to swap for common shares of Altek Biotechnology Corporation at $10 per share and obtained 40 million shares. The split was resolved by the shareholders on June 2, 2015. On September 8, 2015, the Board of Directors resolved to set the spin-off date as January 4, 2016. Below are the assets of the segment spun off.
| spun off. | |
|---|---|
| Asset Cash Other prepaid expenses Property, plant and equipment |
January4,2016 |
| 399,272 $ 501 227 |
|
| 400,000 $ |
~28~
D.For the nine-month period ended September 30, 2017, the Company issued 130 thousands shares for employee stock options exercised and the registration for issuance will be completed pursuant to the regulation.
(16) Capital surplus
Pursuant to the R.O.C. Company Act, capital surplus arising from paid-in capital in excess of par value on issuance of common stocks and donations can be used to cover accumulated deficit or to issue new stocks or cash to shareholders in proportion to their share ownership, provided that the Company has no accumulated deficit. Further, the R.O.C. Securities and Exchange Act requires that the amount of capital surplus to be capitalised mentioned above should not exceed 10% of the paidin capital each year. Capital surplus should not be used to cover accumulated deficit unless the legal reserve is insufficient.
| reserve is insufficient. | ||||||||
|---|---|---|---|---|---|---|---|---|
| At January 1, 2017 Employee stock options exercised Subsidiaries' capital increase not participated proportionately to the original shareholding ratio Retirement of employee restricted shares At September 30, 2017 |
Share premium |
Employee stock options |
Difference between consideration and carrying amount of subsidiaries acquired or disposed |
Changes in ownership interests in subsidiaries |
Restricted shares to employees Total 62,085 $ 1,862,914 $ - 2,404 - 369,789 3,957) ( 3,957) ( 58,128 $ 2,231,150 $ |
|||
| 1,746,566 $ 3,656 - - 1,750,222 $ |
52,729 $ 1,252) ( - - 51,477 $ |
1,534 $ - - - 1,534 $ |
- $ - 369,789 - 369,789 $ |
~29~
| At January 1, 2016 Employee stock options expense Cash dividends from capital Issuance of restricted shares to employees Retirement of employee restricted shares Acquisition of ownership interests in subsidiaries At September 30, 2016 |
Share premium |
Employee stock options |
Difference between consideration and carrying amount of subsidiaries acquired or disposed |
Restricted shares to employees Total 40,992 $ 1,975,772 $ - 236 - 134,140) ( 25,713 25,713 4,620) ( 4,620) ( - 47) ( 62,085 $ 1,862,914 $ |
|
|---|---|---|---|---|---|
| 1,880,706 $ - 134,140) ( - - - 1,746,566 $ |
52,493 $ 236 - - - - 52,729 $ |
1,581 $ - - - - 47) ( 1,534 $ |
(17) Retained earnings
-
A. According to the Company’s Articles of Incorporation, the annual earnings, if any, shall first be used to pay all taxes and offset prior years’ operating losses and then 10% of the remaining amount shall be set aside as legal reserve. Special reserve shall be set aside in accordance with the rules set forth in the Securities and Exchange Act, and distributing the remaining amount as common stockholders’ dividends in accordance with the resolution adopted by the Board of Directors and approved at the stockholders’ meeting.
-
B. The amount of dividends appropriated is based on the Company’s current year’s net income and prior years’ retained earnings, taking into account the Company’s financial structure and future operating plans. The distribution ratio of cash dividends to stock dividends is based on the Company’s funding status, diluted earnings per share and other factors. According to the dividend policy adopted by the Board of Directors, cash dividends shall account for at least 20% of the total dividends distributed. Dividends appropriation shall be resolved by the stockholders at the stockholders’ meeting.
-
C. Except for covering accumulated deficit or issuing new stocks or cash to shareholders in proportion to their share ownership, the legal reserve shall not be used for any other purpose. The use of legal reserve for the issuance of stocks or cash to shareholders in proportion to their share ownership is permitted, provided that the balance of the reserve exceeds 25% of the Company’s paid-in capital.
-
D. (a) In accordance with the regulations, the Company shall set aside special reserve from the debit balance on other equity items at the balance sheet date before distributing earnings. When debit balance on other equity items is reversed subsequently, the reversed amount could be included in the distributable earnings.
~30~
-
(b) The amounts previously set aside by the Company as special reserve on initial application of IFRSs in accordance with Jin-Guan-Zheng-Fa-Zi Letter No. 1010012865, dated April 6, 2012, shall be reversed proportionately when the relevant assets are used, disposed of or reclassified subsequently. Such amounts are reversed upon disposal or reclassified if the assets are investment property of land, and reversed over the use period if the assets are investment property other than land.
-
E. The appropriation of 2016 and 2015 earnings had been resolved at the stockholders’ meeting on June 16, 2017 and June 17, 2016, respectively. Details are summarized below:
| Legal reserve Cash dividends |
Dividends per share Amount (in NT dollars) 5,380 $ 215,596 0.8 $ 220,976 $ 2016 |
2015 | 2015 |
|---|---|---|---|
| Amount 5,380 $ 215,596 220,976 $ |
Amount 27,364 $ 134,140 161,504 $ |
Dividends per share (in NT dollars) |
|
| 0.5 $ |
The additional paid-in capital was returned to stockholders as resolved at the stockholders’ meeting on June 17, 2016, the shareholders resolved to return capital surplus amounting to $134,140 (approximately $0.5 per share) to shareholders in the nature of a capital contribution. The appropriation of 2016 and 2015 earnings were the same as that approved by the Board of Directors on March 27, 2017 and March 18, 2016, respectively.
- F. For the information relating to employees’ compensation and directors’ and supervisors’ remuneration, please refer to Note 6(24).
(18) Other equity items
| Other equity items | |||||||
|---|---|---|---|---|---|---|---|
| Foreign currency | Unearned | ||||||
| translationadjustment | compensation | Total | |||||
| At January 1, 2017 | $ | 35,009 |
($ | 60,530) |
($ | 25,521) |
|
| Currency translation differences: | |||||||
| Group | ( | 264,798) |
- | ( | 264,798) |
||
| Associates | 1,262 | - | 1,262 | ||||
| Retirement of restricted shares | - | 6,357 | 6,357 | ||||
| to employees | |||||||
| Share-based payment | - | 26,266 | 26,266 | ||||
| At September 30, 2017 | ($ | 228,527) | ($ | 27,907) | ($ | 256,434) |
~31~
| (19) (20) |
Operating revenue Other income Foreign currency Unearned translation adjustment compensation Total At January 1, 2016 477,768 $ 63,121) ($ 414,647 $ Currency translation differences: Group 461,976) ( - 461,976) ( Associates 8,482) ( - 8,482) ( Issuance of restricted shares to employees - 41,313) ( 41,313) ( Retirement of restricted shares to employees - 7,370 7,370 Share-based payment - 26,187 26,187 At September 30, 2016 7,310 $ 70,877) ($ 63,567) ($ For the three-month period For the three-month period ended September30,2017 ended September30,2016 Sales revenue 2,534,680 $ 2,793,676 $ Service revenue 62,741 97,650 Other revenue 37,526 32,832 Total 2,634,947 $ 2,924,158 $ For the nine-month period For the nine-month period ended September30,2017 ended September30,2016 Sales revenue 7,515,552 $ 7,755,112 $ Service revenue 122,209 332,212 Other revenue 131,335 50,910 Total 7,769,096 $ 8,138,234 $ For the three-month period For the three-month period ended September30,2017 ended September30,2016 Rental revenue 6,529 $ - $ Interest income: Interest income from bank deposits 21,316 10,803 Others 4 16 Dividend income 3,113 610 Other income - others 3,085 18,134 Total 34,047 $ 29,563 $ |
|---|---|
~32~
| Rental revenue Interest income: Interest income from bank deposits Others Dividend income Other income - others Total |
For the nine-month period ended September30,2017 10,770 $ 54,320 32 3,113 10,925 79,160 $ |
For the nine-month period ended September30,2016 |
|---|---|---|
| - $ 39,843 45 610 26,016 |
||
| 66,514 $ |
(21) Other gains and losses
| (22) | Finance costs For the three-month period For the three-month period ended September30,2017 ended September30,2016 Net gains on financial assets at fair value through profit or loss 712 $ 549 $ Net currency exchange (losses) gains 33,450) ( 3,756 Gains (losses) on disposal of property, plant and equipment 421 56) ( Gains on disposal of investment 20 - Other expenses 1,905) ( 53) ( Total 34,202) ($ 4,196 $ For the nine-month period For the nine-month period ended September30,2017 ended September30,2016 Net gains on financial assets at fair value through profit or loss 1,880 $ 1,835 $ Net currency exchange (losses) gains 81,298) ( 19,310 Gains on disposal of property, plant and equipment 460 3,189 Losses on disposal of investment 4,206) ( - Other expenses 2,881) ( 53) ( Total 86,045) ($ 24,281 $ For the three-month period For the three-month period ended September30,2017 ended September30,2016 Interest expense: Bank borrowings 6,257 $ 6,343 $ |
Finance costs For the three-month period For the three-month period ended September30,2017 ended September30,2016 Net gains on financial assets at fair value through profit or loss 712 $ 549 $ Net currency exchange (losses) gains 33,450) ( 3,756 Gains (losses) on disposal of property, plant and equipment 421 56) ( Gains on disposal of investment 20 - Other expenses 1,905) ( 53) ( Total 34,202) ($ 4,196 $ For the nine-month period For the nine-month period ended September30,2017 ended September30,2016 Net gains on financial assets at fair value through profit or loss 1,880 $ 1,835 $ Net currency exchange (losses) gains 81,298) ( 19,310 Gains on disposal of property, plant and equipment 460 3,189 Losses on disposal of investment 4,206) ( - Other expenses 2,881) ( 53) ( Total 86,045) ($ 24,281 $ For the three-month period For the three-month period ended September30,2017 ended September30,2016 Interest expense: Bank borrowings 6,257 $ 6,343 $ |
|---|---|---|
| 6,343 $ |
~33~
| For the nine-month period | For the nine-month period | For the nine-month period | For the nine-month period | |
|---|---|---|---|---|
| ended September30,2017 | ended September30,2016 | |||
| Interest expense: | ||||
| Bank borrowings | $ | 19,807 | $ | 19,223 |
| Expenses by nature | ||||
| For the three-month period | For the three-month period | |||
| ended September30,2017 | ended September30,2016 | |||
| Employee benefit expenses | $ | 321,532 |
$ | 328,035 |
| Depreciation charges on property, plant | ||||
| and equipment | 61,703 | 81,747 | ||
| Amortisation charges on intangible | ||||
| assets | 3,099 | 3,433 | ||
| Total | $ | 386,334 | $ | 413,215 |
| For the nine-month period | For the nine-month period | |||
| ended September30,2017 | ended September30,2016 | |||
| Employee benefit expenses | $ | 970,227 |
$ | 1,085,438 |
| Depreciation charges on property, plant | ||||
| and equipment | 205,604 | 261,217 | ||
| Amortisation charges on intangible | ||||
| assets | 9,901 | 10,557 | ||
| Total | $ | 1,185,732 | $ | 1,357,212 |
| Employee benefit expenses | ||||
| For the three-month period | For the three-month period | |||
| ended September30,2017 | ended September30,2016 | |||
| Wages and salaries | $ | 273,659 |
$ | 272,718 |
| Employee stock options | 6,809 | 8,557 | ||
| Labour and health insurance fees | 16,248 | 17,498 | ||
| Pension costs | 14,252 | 16,054 | ||
| Other personnel expenses | 10,564 | 13,208 | ||
| Total | $ | 321,532 | $ | 328,035 |
| For the nine-month period | For the nine-month period | |||
| ended September30,2017 | ended September30,2016 | |||
| Wages and salaries | $ | 819,807 |
$ | 908,080 |
| Employee stock options | 26,266 | 26,423 | ||
| Labour and health insurance fees | 47,351 | 55,226 | ||
| Pension costs | 44,939 | 55,899 | ||
| Other personnel expenses | 31,864 | 39,810 | ||
| Total | $ | 970,227 | $ | 1,085,438 |
Interest expense: Bank borrowings (23) Expenses by nature
(24) Employee benefit expenses
~34~
-
A. According to the Articles of Incorporation of the Company, when distributing earnings, the Company shall distribute compensation to the employees and pay remuneration to the directors that account for 10% to 20% and no higher than 2%, respectively, of distributable profit of the current period. If a company has accumulated deficit, earnings should be channeled to cover losses. Employees’ compensation can be distributed in the form of shares or in cash. Employees of subsidiaries that the Company holds more than 50% shareholding are entitled to receive aforementioned stock or cash.
-
Abovementioned distributable profit of the current period refers to the pre-tax profit before deduction of employees’ compensation and directors’ remuneration. A company may, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, have the profit distributed as employees’ compensation and directors’ remuneration; and in addition thereto a report of such distribution shall be submitted to the shareholders’ meeting.
-
Before the establishment of the Audit Committee of the Company, the remuneration of the supervisors and the directors shall be pay no higher than 2% of distributable profit of the current period.
-
-
B. For the three-month and nine-month periods ended September 30, 2017 and 2016, employees’ compensation was accrued (reversed) at ($2,558), $0, $1,091 and $0, respectively; directors’ and supervisors’ remuneration was accrued (reversed) at ($340), $0, $146 and $0, respectively. The aforementioned amounts were recognized in salary expenses.
-
C. The 2016 employees’ cash bonus and directors’ and supervisors’ remuneration as appropriated during the stockholders’ meeting on June 16, 2017 were $13,383 and $1,784, respectively. Employees’ bonus and directors’ and supervisors’ remuneration for 2016 as resolved by the stockholders were in agreement with those amounts recognized in the 2016 financial statements.
-
(25) Income tax
-
A. Income tax expense
- (a) Components of income tax expense:
| e tax ome tax expense Components of income tax expense: |
||||
|---|---|---|---|---|
| For the three-month period | For the three-month period | |||
| endedSeptember30,2017 | endedSeptember30,2016 | |||
| Current tax: | ||||
| Current tax on profits for the period | $ | 21,027 |
$ | 5,530 |
| Adjustments in respect of prior | ||||
| years | 2 | ( | 2) |
|
| Total current tax | 21,029 | 5,528 | ||
| Deferred tax: | ||||
| Origination and reversal of | ||||
| temporary differences | 2,821 | 10,095 | ||
| Total deferred tax | 2,821 | 10,095 | ||
| Income tax expense | $ | 23,850 | $ | 15,623 |
~35~
For the nine-month period For the nine-month period ended September 30, 2017 ended September 30, 2016
| Current tax: | ||||||
|---|---|---|---|---|---|---|
| Current tax on profits for the period | $ | 41,556 |
$ | 37,419 |
||
| Adjustments in respect of prior | ||||||
| years | ( | 3,237) |
( | 16,024) |
||
| Total current tax | 38,319 | 21,395 | ||||
| Deferred tax: | ||||||
| Origination and reversal of | ||||||
| temporary differences | 1,637 | ( | 435) |
|||
| Total deferred tax | 1,637 | ( | 435) |
|||
| Income tax expense | $ | 39,956 | $ | 20,960 |
- (b) The income tax charged to other comprehensive income as follows:
For the three-month period For the three-month period ended September 30, 2017 ended September 30, 2016
Translation differences of foreign operations $ 9,722 ($ 50,286) For the nine-month period For the nine-month period ended September 30, 2017 ended September 30, 2016 Translation differences of foreign operations ($ 53,977) ($ 96,359)
-
B. As of September 30, 2017, the Company’s income tax returns through 2014 have been assessed and approved by the Tax Authority.
-
C. Unappropriated retained earnings:
September 30, 2017 December 31, 2016 September 30, 2016
==> picture [448 x 26] intentionally omitted <==
- D. As of September 30, 2017, December 31, 2016 and September 30, 2016, the balance of the imputation tax credit account was $268,826, $279,476 and $260,845, respectively. The creditable tax rate is estimated to be 9.85% for the year ended December 31, 2017 and was 9.86% for the year ended December 31, 2016.
~36~
(26) Earnings (losses) per share
| Earnings (losses) per share | |||||
|---|---|---|---|---|---|
| For the three-monthperiod endedSeptember | 30,2017 | ||||
| Weighted average number of | |||||
| ordinary shares outstanding | Losses per share | ||||
| Amount after tax | (share in thousands) | (in dollars) | |||
| Basic losses per share | |||||
| Loss attributable to ordinary | |||||
| shareholders of the parent | ($ | 10,385) | 265,868 | ($ | 0.04) |
For the three-month period ended September 30, 2017, the Group’s stock options, restricted the right of new employee shares and reward employees have anti-dilution effect. Thus, no diluted losses per share is calculated.
| share is calculated. | |||
|---|---|---|---|
| Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Restricted stock Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Restricted shares to employees Employees' bonus Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares |
For the three-monthperiod endedSeptember30,2016 | ||
| Weighted average number of ordinary shares outstanding Earnings per share Amount after tax (share in thousands) (in dollars) 12,113 $ 265,840 0.05 $ 12,113 $ 501 12,113 $ 266,341 0.05 $ For the nine-monthperiod endedSeptember30,2017 |
Earnings per share (in dollars) |
||
| 0.05 $ |
|||
| 0.05 $ |
|||
| Amount after tax 4,177 $ 4,177 $ 4,177 $ |
Weighted average number of ordinary shares outstanding (share in thousands) 265,849 2,397 207 268,453 |
Earnings per share (in dollars) |
|
| 0.02 $ |
|||
| 0.02 $ |
~37~
| For the nine-monthperiod endedSeptember30,2016 | For the nine-monthperiod endedSeptember30,2016 | For the nine-monthperiod endedSeptember30,2016 | For the nine-monthperiod endedSeptember30,2016 | ||
|---|---|---|---|---|---|
| Weighted average number of | |||||
| ordinary shares outstanding | Loss per share | ||||
| Amount | after tax | (share in thousands) | (in dollars) | ||
| Basic losses per share | |||||
| Loss attributable to ordinary | |||||
| shareholders of the parent | ($ | 34,388) | 265,840 | ($ | 0.13) |
For the nine-month period ended September 30, 2016, the Group’s stock options, restricted the right of new employee shares and reward employees have anti-dilution effect. Thus, no diluted losses per share is calculated.
(27) Transactions with non-controlling interest
- A. Acquisition of additional equity interest in a subsidiary
During the nine-month period ended September 30, 2016, the Group acquired an additional 0.41% shares of its subsidiary –Altek Autotronics Corporation at the amount of $1,483. This transaction resulted in a decrease of $1,436 in the non-controlling interest and a decrease of $47 in the equity attributable to owners of the parent. The effect of the change in ownership interests on the equity attributable to owners of the parent for the nine-month period ended September 30, 2016 is shown below:
| 2016 is shown below: | |||
|---|---|---|---|
| For the nine-month period | |||
| ended September30,2016 | |||
| Carrying amount of non-controlling | |||
| interest acquired | $ | 1,436 |
|
| Consideration paid to non-controlling | |||
| interest | ( | 1,483) |
|
| Capital surplus | |||
| -Difference between proceeds on | |||
| acquisition of or disposal of equity | |||
| interest in a subsidiary and its | |||
| carrying amount | ($ | 47) |
- B. The Group did not acquire share increase raised by a subsidiary proportionally to its interest to the second-tier subsidiary.
Grandson Altek Semiconductor (Cayman) Co., Ltd., a second-tier subsidiary of the Group, increased capital by issuing new shares on June 9 and July 11, 2017. The Group did not acquire shares proportionally to its interest. As a result, the Group decreased its share interest to 21.43%. The transaction increased non-controlling interest by $539,031 and increased the equity attributable to owners of parent by $369,789. The effect of changes in interests in Altek Semiconductor (Cayman) Co., Ltd. on the equity attributable to owners of the parent as of 2017 is shown below:
~38~
| For the nine-month period | For the nine-month period | |
|---|---|---|
| ended September30,2017 | ||
| Cash | $ | 908,820 |
| Carrying amount of non-controlling | ||
| interest | ( | 539,031) |
| Capital surplus-Changes in ownership | ||
| interests in subsidiaries | $ | 369,789 |
(28) Operating leases
The Group leased part of the Taipei office building with operating leases. Contingent rents of $6,529 and $10,770 were recognized for these leases in profit or loss for the three-month and nine-month periods ended September 30, 2017, respectively. The future aggregate minimum lease payments receivable under non-cancellable operating leases are as follows:
| Not more than 1 year More than 1 year but not more than 5 years |
September30,2017 28,921 $ 45,791 74,712 $ |
December31,2016 September30,2016 - $ - $ - - - $ - $ |
|---|---|---|
The Group leases office buildings for operational needs under non-cancellable operating lease agreements. These lease terms are between 2017 and 2027. Most of the lease agreements are renewable at the market price at the end of the lease period. The future aggregate minimum lease payments receivable under non-cancellable operating leases are as follows:
| Not more than 1 year More than 1 year but not more than 5 years Over 5 years |
September30,2017 3,696 $ 14,785 19,406 37,887 $ |
December31,2016 7,289 $ 14,785 22,178 44,252 $ |
September30,2016 10,628 $ 19,224 23,102 52,954 $ |
|---|---|---|---|
~39~
(29) Supplemental cash flow information
A. Investing activities with partial cash payments
| For the nine-month period | For the nine-month period | For the nine-month period | For the nine-month period | For the nine-month period | For the nine-month period | |
|---|---|---|---|---|---|---|
| ended September30,2017 | ended September30,2016 | |||||
| Acquisitions of property, plant, and | ||||||
| equipment | $ | 95,609 |
$ | 31,570 |
||
| Add:Property and equipment and | ||||||
| construction billings payable at | ||||||
| beginning of period | 6,848 | 61,027 | ||||
| Less: Property and equipment and | ||||||
| construction billings payable at end | ||||||
| of period | ( | 20,326) |
( | 1,459) |
||
| Cash paid | $ | 82,131 | $ | 91,138 | ||
| For the nine-month period | For the nine-month period | |||||
| ended September30,2017 | ended September30,2016 | |||||
| Acquisitions of intangible assets | $ | 1,445 |
$ | 15,423 |
||
| Add: Payable at beginning of period | 9,067 | - | ||||
| Less: Payable at end of period | ( | 4,349) |
( | 9,067) |
||
| Cash paid | $ | 6,163 | $ | 6,356 | ||
| Financing activities with no cash flow | effects | |||||
| For the nine-month period | For the nine-month period | |||||
| ended September30,2017 | ended September30,2016 | |||||
| Cash dividends declared | $ | - |
$ | 134,140 |
||
| Capital surplus used to issue cash | ||||||
| to shareholders | - | 134,140 | ||||
| $ | - | $ | 268,280 |
B. Financing activities with no cash flow effects
7. RELATED PARTY TRANSACTIONS
(1) Names of related parties and relationship: None.
(2) Significant transactions and balances with related parties:
No significant related party transactions.
~40~
(3) Key management compensation
| Key management compensation | ||
|---|---|---|
| Salaries and other short-term employee benefits Post-employment benefits Share-based payments Total Salaries and other short-term employee benefits Post-employment benefits Share-based payments Total |
For the three-month period ended September30,2017 5,523 $ 141 2,190 7,854 $ For the nine-month period ended September30,2017 18,802 $ 439 7,394 26,635 $ |
For the three-month period ended September30,2016 |
| 7,137 $ 162 3,013 |
||
| 10,312 $ |
||
| For the nine-month period ended September30,2016 |
||
| 25,966 $ 512 6,053 |
||
| 32,531 $ |
8. PLEDGED ASSETS
None.
9. SIGNIFICANT CONTINGENT LIABILITIES AND UNRECOGNISED CONTRACT COMMITMENTS
Contingencies
-
(1) The GUC (General Unsecured Creditor Trustee) of Eastman Kodak Company (hereunder ‘Kodak’) filed a lawsuit against the Company in the United States Bankruptcy Court for the Southern District of New York, asserting certain payments in 49.2 million transactions prior to Kodak’s bankruptcy were out of ordinary course of business. After discussion, the GUC agreed to withdraw its claim on August 24, 2016, so the suit was dismissed. The Company neither needs to refund nor to make any payment to the GUC.
-
(2) On December 22, 2015, the Company filed a civil complaint against HTC Corporation with the Taiwan Taipei District Court, alleging HTC Corporation’s default in relation to the agreed upon Manufacturing and Supply Agreement and claiming damage of USD 11,126 thousand against HTC Corporation. As of November 13, 2017, the case is still under trial.
10. SIGNIFICANT DISASTER LOSS
None.
11. SIGNIFICANT EVENT AFTER THE BALANCE SHEET DATE
None.
~41~
12. OTHERS
(1) Capital risk management
The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going concern in order to provide returns for shareholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends, return capital or issue new shares to achieve the optimal capital structure.
(2) Financial instruments
- A. Fair value information of financial instruments
The carrying amounts of financial instruments including cash and cash equivalents, notes receivable, accounts receivable, other receivables, refundable deposits (shown as non-current assets), short-term borrowings, accounts payable, other payables, and guarantee deposits received (shown as non-current liabilities) are approximate to their fair value. The fair value information of financial instruments measured at fair value is provided in Note 12(3).
-
B. Financial risk management policies
-
(a) The Group’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk, interest rate risk and price risk), credit risk and liquidity risk. The Group’s overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on the Group’s financial position and financial performance.
-
(b) Risk management is carried out by a central treasury department (Group treasury) under policies approved by the Board of Directors. Group treasury identifies, evaluates and hedges financial risks in close co-operation with the Group’s operating units, as well as provides written principles for overall risk management and policies covering specific areas and matters, such as foreign exchange risk, interest rate risk, credit risk, use of derivative financial instruments and non-derivative financial instruments, and investment of excess liquidity.
-
C. Significant financial risks and degrees of financial risks
-
(a) Market risk
Foreign exchange risk
-
i. The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily with respect to the USD. Foreign exchange risk arises from future commercial transactions, recognised assets and liabilities and net investments in foreign operations.
-
ii. Management has set up a policy to require that group companies hedge their entire foreign exchange risk exposure with Group treasury. Foreign exchange risk arises when future commercial transactions or recognised assets or liabilities are denominated in a currency that is not the entity’s functional currency.
~42~
-
iii. The Group has certain investments in foreign operations, whose net assets are exposed to foreign currency translation risk. Currency exposure arising from the net assets of the Group’s foreign operations is managed primarily through transactions denominated in the relevant foreign currencies.
-
iv. The information on assets and liabilities denominated in foreign currencies whose values would be materially affected by the exchange rate fluctuations is as follows:
September 30, 2017
| (Foreign currency: functional currency) Financial assets Monetary items USD:NTD USD:RMB Financial liabilities Monetary items USD:NTD USD:RMB (Foreign currency: functional currency) Financial assets Monetary items USD:NTD USD:RMB Non-monetary items USD:NTD Financial liabilities Monetary items USD:NTD USD:RMB |
Foreign Currency Amount (In thousands) |
Foreign Currency Amount (In thousands) |
Exchange Rate |
Exchange Rate |
Book Value (NTD) |
Book Value (NTD) |
SensitivityAnalysis | SensitivityAnalysis | SensitivityAnalysis | SensitivityAnalysis | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Extent of Variation |
Effect on Profit or (Loss) |
Effect on Other Comprehensive Income(Loss) |
|||||||||
| 71,152 USD 63,521 USD 69,259 USD 49,649 USD |
21,531 $ 19,221 20,958) ($ 15,024) ( |
||||||||||
| Foreign Currency Amount (In thousands) |
Exchange Rate |
Book Value (NTD) |
|||||||||
| Extent of Variation |
Effect on Profit or (Loss) |
||||||||||
| USD 102,320 USD 75,336 USD 3,930 USD 94,101 USD 61,696 |
32.25 6.937 32.25 32.25 6.937 |
3,299,820 $ 2,429,586 126,757 $ 3,034,757 $ 1,989,696 |
1% 1% 1% 1% 1% |
32,998 $ 24,296 - $ 30,348) ($ 19,897) ( |
|||||||
~43~
September 30, 2016
| (Foreign currency: functional currency) Financial assets Monetary items USD:NTD USD:RMB Non-monetary items USD:NTD Financial liabilities Monetary items USD:NTD USD:RMB |
Foreign Currency Amount (In thousands) |
Exchange Rate |
Book Value (NTD) |
SensitivityAnalysis | SensitivityAnalysis | SensitivityAnalysis |
|---|---|---|---|---|---|---|
| Extent of Variation |
Effect on Profit or (Loss) |
Effect on Other Comprehensive Income(Loss) |
||||
| USD 88,696 USD 66,684 USD 4,089 USD 85,164 USD 54,628 |
31.360 6.6778 31.360 31.360 6.6778 |
2,781,507 $ 2,091,210 128,245 $ 2,670,743 $ 1,713,134 |
1% 1% 1% 1% 1% |
27,815 $ 20,912 - $ 26,707) ($ 17,131) ( |
- $ - 1,282 $ - $ - |
|
- v. Total exchange gain, including realized and unrealized arising from significant foreign exchange variation on the monetary items held by the Group for the three-month and ninemonth periods ended September 30, 2017 and 2016 amounted to ($33,450), $3,756, ($81,298) and $19,310, respectively.
Interest rate risk
Interest risk arises from the changes of market interest rate causing fluctuation in financial instruments’ fair value or cash received and paid in the future.
The Group raised short-term borrowings at fixed rates during the nine-month periods ended September 30, 2017 and 2016, and thus had no significant cash flow interest rate risk.
Price risk
The Group is exposed to price risk because of investments held by the Group. The Group sets limits to control the transaction volume and stop-loss amount to reduce its market risk.
(b) Credit risk
- i. Credit risk refers to the risk of financial loss to the Group arising from default by the clients or counterparties of financial instruments on the contract obligations. According to the Group’s credit policy, each local entity in the Group is responsible for managing and analyzing the credit risk for each of their new clients before standard payment and delivery terms and conditions are offered. Internal risk control assesses the credit quality of the customers, taking into account their financial position, past experience and other factors. Individual risk limits are set based on internal or external ratings, the utilization of credit limits is regularly monitored. Credit risk arises from cash and cash equivalents
~44~
and deposits with banks and financial institutions, as well as credit exposures to customers, including outstanding receivables and committed transactions.
-
ii. No credit limits were exceeded during the reporting periods, and management does not expect any significant losses from non-performance by these counterparties for the ninemonth periods ended September 30, 2017 and 2016.
-
iii. The individual analysis of financial assets that had been impaired is provided in the statement for each type of financial asset in Note 6.
-
iv. The credit quality information of financial assets that are neither past due nor impaired or past due and not impaired is provided in the statement in Note 6(3).
-
(c) Liquidity risk
-
i. Cash flow forecasting is performed in the operating entities of the Group and aggregated by Group treasury. Group treasury monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities. Such forecasting takes into consideration the Group’s debt financing plans, and compliance with internal balance sheet ratio targets.
-
ii. Surplus cash held by the operating entities over and above the balance required for working capital management are transferred to the Group treasury. Group treasury invests surplus cash in interest bearing current accounts, time deposits and marketable securities, choosing instruments with appropriate maturities or sufficient liquidity to provide sufficient head-room as determined by the above-mentioned forecasts.
-
iii. The table below analyses the Group’s non-derivative financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet date to the contractual maturity date for non-derivative financial liabilities. The amounts disclosed in the table are the contractual undiscounted cash flows.
| Non-derivative financial liabilities: September 30, 2017 Short-term borrowings Accounts payable Other payables Guarantee deposits recevied Non-derivative financial liabilities: December 31, 2016 Short-term borrowings Accounts payable Other payables Guarantee deposits recevied |
Less than 1year 2,366,000 $ 1,874,940 427,830 - Less than 1year 2,415,000 $ 2,417,239 445,206 - |
Over 1year |
|---|---|---|
| - $ - - 23,979 Over 1year |
||
| - $ - - 10,094 |
~45~
Non-derivative financial liabilities:
| Non-derivative financial liabilities: | ||
|---|---|---|
| September 30, 2016 Short-term borrowings Notes payable Accounts payable Other payables Guarantee deposits recevied |
Less than 1year 2,225,000 $ 2,010 2,118,755 711,799 - |
Over 1year |
| - $ - - - 9,512 |
-
(3) Fair value estimation
-
A. The different levels that the inputs to valuation techniques are used to measure fair value of financial and non-financial instruments have been defined as follows:
-
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date. A market is regarded as active where a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The fair value of the Group’s investment in listed beneficiary certificates, on-the-run derivative instruments with quoted market prices is included in Level 1.
-
Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
-
Level 3: Unobservable inputs for the asset or liability. The fair value of the Group’s investment in equity investment without active market is included in Level 3.
-
-
B. The related information of financial and non-financial instruments measured at fair value by level on the basis of the nature, characteristics and risks of the assets and liabilities at September 30, 2017, December 31, 2016 and September 30, 2016 is as follows:
| September 30, 2017 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Beneficiary certificate |
Level 1 862,137 $ |
Level 2 - $ |
Level3 - $ |
Total |
|---|---|---|---|---|
| 862,137 $ |
~46~
| December 31,2016 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Beneficiary certificate September 30, 2016 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Beneficiary certificate |
Level 1 693,709 $ Level 1 852,938 $ |
Level 2 - $ Level 2 - $ |
Level3 - $ Level3 - $ |
Total |
|---|---|---|---|---|
| 693,709 $ |
||||
| Total | ||||
| 852,938 $ |
- A. The methods and assumptions the Group used to measure fair value are as follows:
The instruments the Group used market quoted prices as their fair values (that is, Level 1) are listed below by characteristics:
Open-end fund
Market quoted price Net asset value
13. SUPPLEMENTARY DISCLOSURES
(1) Significant transactions information
-
A. Loans to others: None.
-
B. Provision of endorsements and guarantees to others: None.
-
C. Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures) : Please refer to table 1.
-
D. Acquisition or sale of the same security with the accumulated cost exceeding NT$300 million or 20% of the Company’s paid-in capital: None.
-
E. Acquisition of real estate reaching NT$300 million or 20% of paid-in capital or more: None.
-
F. Disposal of real estate reaching NT$300 million or 20% of paid-in capital or more: None.
-
G. Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paid-in capital or more: Please refer to table 2.
-
H. Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more: Please refer to table 3.
-
I. Trading in derivative financial instruments undertaken during the reporting periods: None.
-
J. Significant inter-company transactions during the reporting periods: Please refer to table 4.
~47~
(2) Information on investees
Names, locations and other information of investee companies (not including investees in Mainland China): Please refer to table 5.
(3) Information on investments in Mainland China
-
A. The related information of investments in Mainland China: Please refer to table 6.
-
B. Significant transactions, either directly or indirectly through a third area, with investee companies in the Mainland Area:
For the significant purchases, sales, accounts payable and accounts receivable transactions between the Company and the investee companies in Mainland China through its subsidiaries, please refer to tables 2 and 4.
14. SEGMENT INFORMATION
(1) General information
The Group mainly operates in one segment. The Chief Operating Decision-Maker reviews the Group’s reporting to assess performance and allocate resources. The Group mainly has a single reportable segment.
(2) Measurement of segment information
The Group has a single reportable segment. The revenue from external customers, the related gain or loss, and the assets correspond with the consolidated revenue, consolidated operating income, and consolidated assets.
(3) Information about segment profit or loss, assets and liabilities
None.
~48~
Altek Corporation and subsidiaries
Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures)
September 30, 2017
| September 30, 2017 | |||||||
|---|---|---|---|---|---|---|---|
| Table 1 Securities held by |
Marketable securities | Relationship with the securities issuer |
General ledger account |
As ofSeptember30,2017 Expressed in thousands of NTD (Except as otherwise indicated) |
|||
| Number of shares | Bookvalue | Ownership (%) | Fairvalue | ||||
| Altek Corporation " " Altek (Kunshan) Co., Ltd. " Altek Investment Co., Ltd. Altek Semiconductor Corporation Altek Biotechnology Corporation |
Gianta Co., Ltd. - Common stock Yung Li Investments Inc. - Common stock Hua-chuang Automobile Information Technical Center Co., Ltd. - Common stock Guangdong Kingding Optical Technology Co., Ltd. CPEC Huachuang Private Equity (Kunshan) Enterprise (Limited Partnership) Money Market Fund Money Market Fund Money Market Fund |
Director None None None None None None None |
Financial assets carried at cost -non-current " " " " Financial assets at fair value through profit or loss-current " " |
762,876 923,806 10,000,000 1,200,000 N/A 2,487,654 10,186,089 30,245,834 |
10,312 $ 3,192 93,450 5,471 45,594 39,861 249,425 572,851 |
14.55% 4.84% 2.00% 6.45% (Note) N/A N/A N/A |
10,312 $ 3,192 93,450 5,471 45,594 39,861 249,425 572,851 |
Note : 1% of CPEC Huachuang Private Equity (Kunshan) Enterprise (Limited Partnership)’s capital contribution.
Table 1, Page 1
Table 2
Altek Corporation and subsidiaries
Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paid-in capital or more
For the nine-month period ended September 30, 2017
Expressed in thousands of NTD
(Except as otherwise indicated)
| Purchaser/seller | Counterparty | Relationship with the counterparty |
Transaction | Transaction | Differences in transaction terms compared to third party transactions |
Differences in transaction terms compared to third party transactions |
Notes/accounts receivable(payable) |
Notes/accounts receivable(payable) |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Purchases (sales) |
Amount | Percentage of total purchases (sales) |
Credit term | Unitprice | Credit term | Balance | Percentage of total notes/accounts receivable(payable) |
|||
| Altek Corporation Altek International Investment Co., Ltd. Altek Semiconductor Corporation Altek Biotechnology Corporation Altek (Kunshan) Co., Ltd. Altek Trading (Shanghai) Limited " |
Altek International Investment Co., Ltd. Altek (Kunshan) Co., Ltd. Altek International Investment Co., Ltd. " " " Altek (Kunshan) Co., Ltd. |
Parent and affiliated company " " The same ultimate parent company Parent and affiliated company " The same ultimate parent company |
Purchases Purchases Purchases Purchases Purchases Purchases Purchases |
2,921,250 $ 5,182,207 655,731 489,512 164,500 520,748 261,456 |
96% 100% 72% 100% 3% 60% 30% |
Net 120 days Net 75 days " " " " " |
Approximately the same price with third parties " " " " " " |
Note " " " " " " |
1,434,738) ($ 988,398) ( 323,574) ( 256,216) ( - 96,791) ( 51,114) ( |
94% 97% 86% 100% 0% 65% 35% |
Note: The payment term with third parties was net 60~120 days.
Table 2, Page 1
Altek Corporation and subsidiaries
Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more
September 30, 2017
| Table 3 Creditor |
Counterparty | Relationship with the counterparty |
Balance as atSeptember30,2017 | Turnover rate | Overdue receivables | Overdue receivables | Amount collected subsequent to the balance sheet date Allowance for doubtful accounts Expressed in thousands of NTD (Except as otherwise indicated) |
Amount collected subsequent to the balance sheet date Allowance for doubtful accounts Expressed in thousands of NTD (Except as otherwise indicated) |
|---|---|---|---|---|---|---|---|---|
| Amount | Action taken | |||||||
| Altek International Investment Co., Ltd. " " Altek (Kunshan) Co., Ltd. |
Altek Corporation Altek Semiconductor Corporation Altek Biotechnology Corporation Alteck International Investment Co., Ltd. |
Parent company Parent company The same ultimate parent company Parent company |
1,434,738 $ 323,574 256,216 988,398 |
2.25 3.10 3.22 4.80 |
- $ - - - |
N/A N/A N/A N/A |
241,291 $ 59,968 44,374 511,484 |
- $ - - - |
Table 3, Page 1
Altek Corporation and subsidiaries
Table 4
Significant inter-company transactions during the reporting periods
For the nine-month period ended September 30, 2017
Expressed in thousands of NTD
(Except as otherwise indicated)
Transaction
| Transaction | ||||||
|---|---|---|---|---|---|---|
| Companyname | Counterparty | Relationship (Note 1) |
General ledger account | Amount | Transaction terms | Percentage of consolidated total operating revenues or total assets(Note 2) |
| Altek Corporation " Altek International Investment Co., Ltd. " Altek Semiconductor Corporation " Altek Biotechnology Corporation " Altek (Kunshan) Co., Ltd. " Altek Trading (Shanghai) Limited " " " |
Altek International Investment Co., Ltd. " Altek (Kunshan) Co., Ltd. " Altek International Investment Co., Ltd. " " " " " " " Altek (Kunshan) Co., Ltd. " |
(1) (1) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) |
Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable |
2,921,250 $ 1,434,738 5,182,207 988,398 655,731 323,574 489,512 256,216 164,500 - 520,748 96,791 261,456 51,114 |
Net 120 days " Net 75 days " " " " " " " " " " " |
38% 10% 67% 7% 8% 2% 6% 2% 2% 0% 7% 1% 3% 0% |
Note 1: Relationship between transaction and counterparty is classified into the following categories:
-
(1) Parent company to subsidiary.
-
(2) Subsidiary to parent company.
-
(3) Subsidiary to subsidiary.
Note 2: Regarding percentage of transaction amount to consolidated total operating revenues or total assets, it is computed based on period-end balance of transaction to consolidated total assets for balance sheet accounts and based on accumulated transaction amount for the period to consolidated total operating revenues for income statement accounts.
Note 3: The Company may decide to disclose or not to disclose transaction details in this table based on the Materiality Principle.
Table 4, Page 1
Altek Corporation and subsidiaries
Information on investees
Table 5
Expressed in thousands of NTD (Except as otherwise indicated)
For the nine-month period ended September 30, 2017
| Investor | Investee | Location | Main business activities | Initial invest | ment amount | Shares he | ld as at September | 30,2017 | Net profit (loss) of the investee for the nine-month period ended September 30,2017 |
Investment income(loss) recognised by the Company for the nine-month period ended September 30,2017 |
Footnote |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as at September 30, 2017 |
Balance as at December 31, 2016 |
Number of shares | Ownership (%) | Book value | |||||||
| Altek Corporation " " " " Altek International Investment Co., Ltd. " " Altek Semiconductor (Cayman) Co., Ltd. Altek Biotechnology Holding (Cayman) Co., Ltd. |
Altek International Investment Co., Ltd. Altek Japan Corporation Altek Investment Co., Ltd. Altek Autotronics Corporation Altek International Holding (BVI) Co, Ltd. Altek Lab Inc. JinJing Optical Technology Co., ltd. Altek Semiconductor (Cayman) Co., Ltd. Altek Semiconductor Corporation Altek Biotechnology Corporation |
British Virgin Islands Japan Republic of China Republic of China British Virgin Islands U.S.A. Samoa Cayman Islands Republic of China Republic of China |
Investment and general business operations Sale and design of optical instruments Investment Research design, manufacture and sales of car electronic components Investment and general business operations Design service Investment and general business operations Investment and general business operations Research design and sales of ASIC Research and development, manufacture and sales of biotechnology |
2,910,046 $ 2,869 50,000 - 415,376 111,349 105,910 186,015 200,000 415,376 |
3,033,618 $ 2,869 50,000 184,080 415,376 111,349 105,910 186,015 200,000 415,376 |
88,662,059 1,000 5,000,000 - 12,865,921 11,311,875 3,500,000 20,000,000 20,000,000 40,100,000 |
100% 100% 100% - 100% 100% 23.33% 50% 100% 100% |
9,118,009 $ 10,963 39,879 - 456,715 59,895 - 659,283 372,011 456,715 |
62,861 $ 586) ( 4,735 92) ( 23,367 1,675 21,555) ( 8,719) ( 5,726) ( 23,367 |
62,861 $ 586) ( 69) ( - 23,367 757 - 9,073) ( 7,670) ( 23,367 |
Note 1 Note 3 Note 2 Note 3 |
Note 1: On June 30, 2017, Altek Corporation consummated a short-form merger with Altek Autotronics Corporation and the former is the surviving company.
Note 2: Common stock of 9,311,875 shares and preferred stock of 2,000,000 shares.
Note 3: In June 2016, The share holding of Altek Biotechnology Corporation was changed to be owned by Altek Biotechnology Holding (Cayman) Co., Ltd. , which is a subsidiary of Altek International Holding (BVI) Co., Ltd.
Table 5, Page 1
Altek Corporation and subsidiaries
Information on investments in Mainland China For the nine-month period ended September 30, 2017
Table 6
Expressed in thousands of NTD (Except as otherwise indicated)
| Investee in Mainland China |
Main business activities | Paid-in capital | Investment method (Note 1) |
Accumulated amount of remittance from Taiwan to Mainland China as of January1,2017 |
Amount remitte Mainland C remitted back the nine-monthperiod e |
d from Taiwan to hina/Amount to Taiwan for nded September 30,2017 |
Accumulated amount of remittance from Taiwan toMainland China as of September 30,2017 |
Net profit (loss) of investee for the nine-month period ended September 30,2017 |
Ownership held by the Company (direct or indirect) |
Investment income (loss) recognised by the Company for the nine-month period ended September 30,2017 |
Book value of investments in Mainland China as of September 30,2017 |
Accumulated amount of investment income remitted back to Taiwan as of September 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remitted to Mainland China | Remitted back to Taiwan | |||||||||||
| Altek (Kunshan) Co., Ltd. (Note 2) Altek EMS (Kunshan) Co., Ltd. (Note 3) Altek Trading (Shanghai) Limited Kinko Optical (Suzhou) Co., Ltd. Phoenix Optical (Shanghai) Co., Ltd. Altek Precision (Kunshan) Co., Ltd. Altek Optical Technology (Kunshan) Co., Ltd. Altek Semiconductor (Shanghai) Co., Ltd. |
Manufacture and sale of digital still cameras and its accessories Manufacture and sale of related engineering services Wholesale, import and export of digital cameras, digital video cameras and their associated accessories Manufacture and sale of optical components Manufacturing and marketing of digital cameras and its key components, photo sensor and optoelectronic equipment Design, manufacture and sales of digital camera parts Manufacture and sales of digital camera and its accessories and optical components Imaging technologies, electronic software and hardware development, IC design and development, technology service, and wholesale, import and export of related products. |
1,500,896 $ 151,300 257,210 453,900 478,804 417,588 453,900 15,130 |
2 2 2 2 2 2 2 2 |
1,361,700 $ 274,852 257,210 105,910 268,238 417,588 453,900 - |
- $ - - - - - - - |
- $ - - - ( 123,572) - - - |
1,361,700 $ 274,852 257,210 105,910 144,666 417,588 453,900 - |
68,719 $ 894 25,618 ( 18,429) - ( 3,311) ( 9,059) 5,345) ( |
100% 100% 100% 23.33% - 100% 100% 50% |
68,719 $ 894 25,618 - - ( 3,311) ( 9,059) 2,741) ( |
3,856,400 $ 762,159 300,507 - - 150,277 128,849 10,355 |
- $ - - - - - - - |
Note 1: Investment methods are classified into the following three categories; fill in the number of category each case belongs to:
(1)Directly invest in a company in Mainland China. (2)Through investing in an existing company in the third area,which then investeed in the investee in Mainland China. (3)Others. Note 2: Including retained earnings capitalized of US$4,600 (In thousand of US dollars). Note 3: Including retained earnings capitalized of US$3,600 (In thousand of US dollars). Note 4: On May 8, 2017, Phoenix Optical (Shanghai) Co., Ltd. has completed liquidation.
| Companyname | Accumulated amount of remittance from Taiwan to Mainland China as of September 30,2017 |
Investment amount approved by the Investment Commission of the Ministryof Economic Affairs(MOEA) |
Ceiling on investments in Mainland China imposed bythe Investment Commission of MOEA |
|---|---|---|---|
| Altek Corporation | 3,015,826 $ |
3,078,773 $ |
- $ |
Note:According to “REGULATIONS GOVERNING THE APPROVAL OF INVESTMENT OR TECHNICAL IN MAINLAND CHINA”on August 29, 2008, Altek Corporation obtained the approval
from the Industrial Development Bureau of Ministry of Economics Affairs issued to Headquarters, so there is no need to compute the ceiling amount of the Company.
Table 6, Page 1